Additional Information
Book Details
Abstract
This work presents a definitive interpretation of the current status of and future trends in natural products—a dynamic field at the intersection of chemistry and biology concerned with isolation, identification, structure elucidation, and chemical characteristics of naturally occurring compounds such as pheromones, carbohydrates, nucleic acids, and enzymes. With more than 1,800 color figures, Comprehensive Natural Products II features 100% new material and complements rather than replaces the original work (©1999).
- Reviews the accumulated efforts of chemical and biological research to understand living organisms and their distinctive effects on health and medicine
- Stimulates new ideas among the established natural products research community—which includes chemists, biochemists, biologists, botanists, and pharmacologists
- Informs and inspires students and newcomers to the field with accessible content in a range of delivery formats
- Includes 100% new content, with more than 6,000 figures (1/3 of these in color) and 40,000 references to the primary literature, for a thorough examination of the field
- Highlights new research and innovations concerning living organisms and their distinctive role in our understanding and improvement of human health, genomics, ecology/environment, and more
- Adds to the rich body of work that is the first edition, which will be available for the first time in a convenient online format giving researchers complete access to authoritative Natural Products content
Advanced praise for Comprehensive Natural Products II: Writing in the preface, renowned natural products chemist Koji Nakanishi praises “Lew Mander and Hung-Wen (Ben) Liu for having assembled an extraordinary team of editors for the nine volumes, who in turn have brought together top natural products scientists to review the respective topics…CONAP II should not be regarded merely as a reference source. Instead, one can take it from the bookshelf, flip through the pages, and go through some sections for one’s entertainment and knowledge enhancement.
Reviews of the first edition: "A marvelous and monumental piece of work." --Journal of the American Chemical Society
"This work is essential for libraries at institutions where natural product research is seriously pursued or contemplated." --Choice
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
e9780080453811v1 | 1 | ||
Cover | 1 | ||
Title Page | 4 | ||
Copyright Page | 5 | ||
Contents | 6 | ||
Contributors | 8 | ||
Preface | 12 | ||
Introduction | 14 | ||
Editors in Chief | 18 | ||
Volume Editors | 20 | ||
1.01 Overview and Introduction | 26 | ||
1.02 Unsaturated Fatty Acids | 30 | ||
1.02.1 Introduction | 30 | ||
1.02.2 Monounsaturated Fatty Acids | 32 | ||
1.02.3 Methylene-Interrupted Polyunsaturated Fatty Acids | 45 | ||
1.02.4 Unusual Unsaturated Fatty Acids | 49 | ||
1.02.5 Summary and Future Prospects | 53 | ||
Abbreviations | 53 | ||
References | 54 | ||
1.03 Prostaglandin Endoperoxide Synthases: Structure, Function, and Synthesis of Novel Lipid Signaling Molecules | 60 | ||
1.03.1 Introduction | 61 | ||
1.03.2 Physiological Functions and Regulation of PGHS Isoforms | 62 | ||
1.03.3 Structural Determinants for Arachidonic Acid Metabolism by PGHS | 66 | ||
1.03.4 Role of PGHS in the Biosynthesis of Novel Acidic Eicosanoids | 72 | ||
1.03.5 Biosynthesis, Degradation, and Pharmacology of Prostaglandin-Glycerylesters | 78 | ||
1.03.6 Biosynthesis, Degradation, and Pharmacology of Prostaglandin-Ethanolamides | 80 | ||
1.03.7 Metabolism of Other Arachidonoyl Amides by PGHS | 81 | ||
1.03.8 Conclusions | 81 | ||
Abbreviations | 81 | ||
References | 82 | ||
1.04 Mycolic Acid/Cyclopropane Fatty Acid/Fatty Acid Biosynthesis and Health Relations | 90 | ||
1.04.1 Introduction | 91 | ||
1.04.2 Structural Variation, Biosynthesis, and Function of the Core Cell Envelope Mycolic Acids | 92 | ||
1.04.3 Trehalose-Based Glycolipids | 107 | ||
1.04.4 Phthiocerol-Based Glycolipids | 126 | ||
1.04.5 Lipoarabinomannan and Phosphatidylinositides | 133 | ||
1.04.6 Exotic Glycolipids and Glycopeptidolipids | 137 | ||
1.04.7 Conclusions and Outlook | 156 | ||
Abbreviations | 156 | ||
References | 158 | ||
1.05 Microbial Type III Polyketide Synthases | 172 | ||
1.05.1 Introduction | 172 | ||
1.05.2 Plant Type III PKSs | 174 | ||
1.05.3 Type III PKSs from Actinobacteria | 176 | ||
1.05.4 Type III PKSs from Proteobacteria | 184 | ||
1.05.5 Type III PKSs from Eukaryotic Microbes | 188 | ||
1.05.6 Conclusions and Future Perspectives | 190 | ||
Abbreviations | 192 | ||
References | 193 | ||
1.06 Plant Type III PKS | 196 | ||
1.06.1 Introduction | 196 | ||
1.06.2 Functional Diversity and Catalytic Potential | 199 | ||
1.06.3 Enzyme Structure and Site-Directed Mutagenesis | 230 | ||
1.06.4 Protein Engineering | 239 | ||
1.06.5 Combinational Biosynthesis | 240 | ||
1.06.6 Conclusions | 245 | ||
Acknowledgments | 245 | ||
Abbreviations | 245 | ||
References | 246 | ||
1.07 Type II PKS | 252 | ||
1.07.1 Introduction | 253 | ||
1.07.2 Enzymes of Type II PKS-Derived Natural Products | 253 | ||
1.07.3 Natural Structural Diversity | 264 | ||
1.07.4 Artificial Structural Diversity through Combinatorial Biosynthesis | 295 | ||
1.07.5 Conclusions | 317 | ||
Acknowledgments | 317 | ||
Glossary | 317 | ||
References | 318 | ||
1.08 Structural Enzymology of Polyketide Synthase: The Structure–Sequence–Function Correlation | 330 | ||
1.08.1 Introduction | 330 | ||
1.08.2 Fatty Acid Biosynthesis and Fatty Acid Synthase | 332 | ||
1.08.3 The Type II PKS | 335 | ||
1.08.4 Structural Enzymology of Individual Type II PKS Enzymes | 339 | ||
1.08.5 Protein–Protein Interactions and Transport of Polyketide Intermediates between Enzymes | 364 | ||
1.08.6 Summary and Future Prospects | 365 | ||
Acknowledgments | 365 | ||
Glossary | 366 | ||
Abbreviations | 366 | ||
Nomenclature | 367 | ||
References | 367 | ||
1.09 Fungal Type I Polyketides | 372 | ||
1.09.1 Introduction | 372 | ||
1.09.2 Diversity of Fungal Polyketides | 373 | ||
1.09.3 Biosynthesis of Fungal Polyketides | 379 | ||
1.09.4 Mixed Polyketide/Nonribosomal Peptides | 397 | ||
1.09.5 Meroterpenoids | 399 | ||
1.09.6 Post-PKS Reactions in Fungi | 401 | ||
1.09.7 Conclusions | 403 | ||
References | 405 | ||
1.10 Type I Modular PKS | 410 | ||
1.10.1 Introduction to Polyketides | 411 | ||
1.10.2 Fatty Acid Biosynthesis – Reactions and Enzymes | 413 | ||
1.10.3 Polyketide Biosynthesis – Reactions and Enzymes | 417 | ||
1.10.4 Mechanism and Structural Specificity of Precursor Loading within the Modules of the DEBS | 424 | ||
1.10.5 Experimental Investigation of Stereospecificity of the Reactions of the DEBS Chain-Extension Cycles | 428 | ||
1.10.6 Studies of the Quaternary Structure of the Type I FAS | 434 | ||
1.10.7 Studies of the Structure of the DEBS Modules | 440 | ||
1.10.8 Current Proposals for the Topology of the DEBS Modules and Multienzymes | 443 | ||
1.10.9 Other Polyketide Synthases | 448 | ||
1.10.10 Commercial Applications of Genetic Engineering of Modular Polyketide Synthases | 463 | ||
1.10.11 Future Perspectives | 469 | ||
Abbreviations | 471 | ||
Nomenclature | 472 | ||
References | 472 | ||
1.11 NRPS/PKS Hybrid Enzymes and Their Natural Products | 478 | ||
1.11.1 Introduction | 479 | ||
1.11.2 Medicinally Important PK/NRP Natural Products and Pathways | 483 | ||
1.11.3 Trans-AT Domain Pathways – a Rich Source of Unusual Biochemistry | 492 | ||
1.11.4 Engineering, Technology Development, and Other Future Directions for Hybrid PK/NRP Systems | 506 | ||
1.11.5 Conclusions | 508 | ||
Acknowledgment | 509 | ||
Abbreviations | 509 | ||
References | 510 | ||
1.12 Mevalonate Pathway in Bacteria and Archaea | 518 | ||
1.12.1 Introduction | 518 | ||
1.12.2 Overview of the Mevalonate Pathway | 519 | ||
1.12.3 Two Classes of HMG-CoA Reductase | 522 | ||
1.12.4 Two Types of IPP Isomerase | 527 | ||
1.12.5 Biosynthetic Gene Clusters of Secondary Metabolites from Actinomycetes | 535 | ||
1.12.6 Mevalonate Fermentation | 536 | ||
1.12.7 Conclusions | 537 | ||
Abbreviations | 537 | ||
Nomenclature | 537 | ||
References | 538 | ||
1.13 Methylerythritol Phosphate Pathway | 542 | ||
1.13.1 Introduction | 543 | ||
1.13.2 Identification of the Genes and the Enzymes | 547 | ||
1.13.3 Distribution of the MEP Pathway | 567 | ||
1.13.4 Openings and Further Developments | 569 | ||
Acknowledgments | 573 | ||
Abbreviations | 573 | ||
References | 574 | ||
1.14 Prenyltransferase | 582 | ||
1.14.1 Introduction | 582 | ||
1.14.2 (E)-Prenyltransferases | 586 | ||
1.14.3 (Z)-Prenyl Diphosphate Synthases | 594 | ||
1.14.4 Conclusions | 604 | ||
Glossary | 605 | ||
References | 605 | ||
1.15 Advances in the Enzymology of Monoterpene Cyclization Reactions | 610 | ||
1.15.1 Introduction | 610 | ||
1.15.2 Cyclization Chemistry | 613 | ||
1.15.3 Structural Studies | 620 | ||
1.15.4 Conclusions | 630 | ||
Acknowledgments | 630 | ||
References | 631 | ||
1.16 Sesquiterpenes | 634 | ||
1.16.1 Introduction | 634 | ||
1.16.2 Classification of Sesquiterpenes | 635 | ||
1.16.3 Decorating the Sesquiterpene Scaffolds | 655 | ||
1.16.4 Future Challenges | 660 | ||
Glossary | 661 | ||
References | 663 | ||
1.17 Diterpenes | 668 | ||
1.17.1 Introduction | 668 | ||
1.17.2 Labdane-Type Diterpenes | 669 | ||
1.17.3 Clerodane- and Halimane-Type Diterpenes | 685 | ||
1.17.4 Other types of Diterpenes | 687 | ||
1.17.5 Summary and Future Prospects | 693 | ||
Abbreviations | 694 | ||
References | 694 | ||
1.18 Triterpenes | 698 | ||
1.18.1 Introduction | 698 | ||
1.18.2 Cyclization Mechanism | 699 | ||
1.18.3 Lanosterol/Cycloartenol Synthases | 701 | ||
1.18.4 Plant Triterpene Synthases | 709 | ||
1.18.5 Triterpene Tailoring Steps | 726 | ||
1.18.6 Summary and Future Perspectives | 729 | ||
Abbreviations | 730 | ||
References | 730 | ||
1.19 Bacterial Squalene Cyclase | 734 | ||
1.19.1 Introduction | 734 | ||
1.19.2 The Reaction Mechanism | 736 | ||
1.19.3 The Enzyme Structure | 737 | ||
1.19.4 Site-Directed Mutagenesis | 741 | ||
1.19.5 Substrate Recognition and Catalytic Potential | 744 | ||
1.19.6 Conclusions | 754 | ||
Acknowledgments | 755 | ||
Abbreviations | 755 | ||
References | 755 | ||
1.20 Carotenoids | 758 | ||
1.20.1 Introduction | 758 | ||
1.20.2 Biosynthesis of Basic Structures of Carotenoids | 759 | ||
1.20.3 Biosynthesis of C30 Carotenoids | 761 | ||
1.20.4 Biosynthesis of C40 Carotenoids | 761 | ||
1.20.5 Pathway Engineering for Useful Carotenoid Formation in Escherichia coli | 770 | ||
1.20.6 Pathway Engineering for Useful Carotenoid Formation in Higher Plants | 771 | ||
1.20.7 Conclusion | 775 | ||
Acknowledgment | 775 | ||
Nomenclature | 775 | ||
References | 775 | ||
1.21 Sterol and Steroid Biosynthesis and Metabolism in Plants and Microorganisms | 780 | ||
1.21.1 Introduction | 780 | ||
1.21.2 Sterol and Steroid Biosynthetic Pathways | 781 | ||
1.21.3 Sterol and Steroid Conjugates | 799 | ||
1.21.4 Sterol Degradation | 801 | ||
1.21.5 Transport | 801 | ||
1.21.6 Molecular Regulation of Sterol Biosynthesis | 802 | ||
1.21.7 Functions of Steroids | 803 | ||
Abbreviations | 804 | ||
References | 805 | ||
1.22 Isoprenoid in Actinomycetes | 814 | ||
1.22.1 Introduction | 814 | ||
1.22.2 Cyclic Isoprenoids | 815 | ||
1.22.3 Hybrid Isoprenoids | 826 | ||
Abbreviations | 836 | ||
References | 836 | ||
1.23 Lignans (Neolignans) and Allyl/Propenyl Phenols: Biogenesis, Structural Biology, and Biological/Human Health Considerations | 840 | ||
1.23.1 Introduction | 842 | ||
1.23.2 Definition and Nomenclature | 843 | ||
1.23.3 Chemotaxonomical Diversity: Evolutionary Considerations | 846 | ||
1.23.4 Lignan Early Biosynthetic Steps: 8–89 Phenylpropanoid Coupling | 872 | ||
1.23.5 Downstream Lignan Metabolism | 881 | ||
1.23.6 Other Phenylpropanoid Coupling Modes: 8–29, 8–39 (8–59), and 8–O–49-Linked Lignans | 903 | ||
1.23.7 Allylic (Phenylpropenal) Double Bond Reductases and Phenylcoumaran Benzylic Ether Reductases | 905 | ||
1.23.8 Norlignan Biosynthesis | 914 | ||
1.23.9 Allyl-/Propenylphenol Biosynthesis | 917 | ||
1.23.10 Biological Properties in Planta and in Human Usage | 931 | ||
Acknowledgments | 941 | ||
References | 941 | ||
1.24 Plant Phenolics: Phenylpropanoids | 954 | ||
1.24.1 Introduction | 954 | ||
1.24.2 New Enzyme Functions in Phenylpropanoid Metabolism | 956 | ||
1.24.3 Flavonoids | 962 | ||
1.24.4 Functional Genomics and Evolution of Phenylpropanoid/Flavonoid Biosynthesis | 991 | ||
References | 993 | ||
1.25 Alkaloids | 1002 | ||
1.25.1 What Is an Alkaloid? | 1002 | ||
1.25.2 Classes of Alkaloids | 1002 | ||
1.25.3 Function and Diversity of Alkaloids | 1003 | ||
1.25.4 Strategies for Elucidating Alkaloid Biosynthesis | 1007 | ||
1.25.5 Benzylisoquinoline Alkaloid Biosynthesis | 1012 | ||
1.25.6 Monoterpene Indole Alkaloid Biosynthesis | 1017 | ||
1.25.7 Tropane Alkaloid Biosynthesis | 1024 | ||
1.25.8 Purine Alkaloid Biosynthesis | 1026 | ||
1.25.9 Conclusions and Outlook | 1026 | ||
Glossary | 1028 | ||
References | 1028 | ||
e9780080453811v2 | 1034 | ||
Cover | 1034 | ||
Title page | 1037 | ||
Copyright page\r | 1038 | ||
Contents | 1039 | ||
Contributors | 1041 | ||
Preface | 1045 | ||
Introduction | 1047 | ||
Editors-In-Chief | 1051 | ||
Volume Editors | 1053 | ||
2.01 Overview and Introduction | 1059 | ||
2.02 Terrestrial Plants as a Source of Novel Pharmaceutical Agents | 1063 | ||
2.02.1 Introduction | 1064 | ||
2.02.2 Plants as a Source of Bioactive Compounds | 1064 | ||
2.02.3 Anticancer Compounds | 1064 | ||
2.02.4 Anti-HIV Agents | 1080 | ||
2.02.5 Antimalarial Compounds | 1083 | ||
2.02.6 Cardiovascular and Metabolic Diseases | 1084 | ||
2.02.7 CNS Active Agents | 1087 | ||
2.02.8 Outlook and Future Prospects | 1090 | ||
References | 1090 | ||
2.03 Marine Macroalgal Natural Products | 1099 | ||
2.03.1 Introduction | 1099 | ||
2.03.2 Isoprenoids | 1100 | ||
2.03.3 Fatty Acid and Polyketide Metabolites | 1109 | ||
2.03.4 Shikimate Metabolites | 1113 | ||
2.03.5 Nonribosomal Peptide Metabolites | 1114 | ||
2.03.6 Alkaloid Metabolites | 1115 | ||
2.03.7 Glycolipids | 1117 | ||
2.03.8 Conclusion | 1119 | ||
Acknowledgments | 1119 | ||
Abbreviations | 1119 | ||
Nomenclature | 1120 | ||
References | 1120 | ||
2.04 Insect Natural Products | 1125 | ||
2.04.1 Introduction | 1125 | ||
2.04.2 Challenges in Arthropod Natural Products Chemistry | 1128 | ||
2.04.3 Terpenoids | 1129 | ||
2.04.4 Fatty Acid and Other Polyacetate Derivatives | 1136 | ||
2.04.5 Polyketides | 1141 | ||
2.04.6 Alkaloids and Amines | 1143 | ||
2.04.7 Nucleoside Derivatives | 1157 | ||
2.04.8 Miscellaneous Compounds | 1158 | ||
2.04.9 Outlook | 1159 | ||
References | 1161 | ||
2.05 Terrestrial Microorganisms – Filamentous Bacteria | 1167 | ||
2.05.1 Introduction | 1167 | ||
2.05.2 Historical Bacterial Metabolites | 1168 | ||
2.05.3 Newer Compounds or Compounds with Recently Described Mechanism of Action | 1174 | ||
Abbreviations | 1192 | ||
References | 1192 | ||
2.06 The Natural Products Chemistry of Cyanobacteria | 1199 | ||
2.06.1 Introduction | 1200 | ||
2.06.2 Trends in the Structures of Cyanobacterial Natural Products | 1201 | ||
2.06.3 Fatty Acid Derivatives from Cyanobacteria | 1208 | ||
2.06.4 Terpenes | 1211 | ||
2.06.5 Saccharides and Glycosides | 1212 | ||
2.06.6 Peptides | 1216 | ||
2.06.7 Polyketides | 1223 | ||
2.06.8 Lipopeptides | 1227 | ||
2.06.9 Conclusion | 1240 | ||
Acknowledgments | 1241 | ||
References | 1241 | ||
2.07 Myxobacteria – Unique Microbial Secondary Metabolite Factories | 1247 | ||
2.07.1 Myxobacteria as Producers of Bioactive Secondary Metabolites | 1247 | ||
2.07.2 Approaches to Exploring the Biosynthetic Potential of Myxobacteria | 1250 | ||
2.07.3 Biosynthesis of Myxobacterial Secondary Metabolites at the Molecular Level | 1253 | ||
2.07.4 Deciphering Regulatory Mechanisms of Secondary Metabolism to Increase Productivity | 1269 | ||
2.07.5 Biotechnological Strategies to Generate Modified Compounds | 1272 | ||
2.07.6 Conclusions | 1276 | ||
Acknowledgments | 1276 | ||
References | 1276 | ||
2.08 Natural Product Diversity from Marine Fungi | 1281 | ||
2.08.1 Introduction | 1281 | ||
2.08.2 Biology of Marine-Derived Fungi | 1281 | ||
2.08.3 Natural Product Chemistry of Marine-Derived Fungi | 1284 | ||
2.08.4 Conclusions | 1315 | ||
Glossary | 1315 | ||
References | 1316 | ||
2.09 Bioactive Metabolites from Marine Dinoflagellates | 1321 | ||
2.09.1 Introduction | 1322 | ||
2.09.2 Amphidinium sp. | 1322 | ||
2.09.3 Alexandrium sp. | 1352 | ||
2.09.4 Dinophysis sp. | 1353 | ||
2.09.5 Durinskia sp. | 1354 | ||
2.09.6 Gambierdiscus toxicus | 1354 | ||
2.09.7 Karenia sp. | 1358 | ||
2.09.8 Karlodinium veneficum | 1360 | ||
2.09.9 Ostreopis siamensis | 1361 | ||
2.09.10 Prorocentrum sp. | 1362 | ||
2.09.11 Protoceratium reticulatum | 1365 | ||
2.09.12 Symbiodinium sp. | 1368 | ||
2.09.13 Biosynthesis of Dinoflagellate Polyketides | 1373 | ||
2.09.14 Prospects | 1376 | ||
Glossary | 1377 | ||
References | 1377 | ||
2.10 Marine Invertebrates: Sponges | 1385 | ||
2.10.1 Introduction | 1386 | ||
2.10.2 Structure and Bioactivities of Metabolites Characteristic to Marine Sponges | 1387 | ||
2.10.3 Sponge Metabolites as Drug Leads | 1410 | ||
2.10.4 Roles of Sponge Metabolites in Marine Ecosystems | 1413 | ||
2.10.5 Conclusions | 1414 | ||
Abbreviations | 1415 | ||
2.11 The Natural Products Chemistry of the Gorgonian Genus Pseudopterogorgia (Octocorallia: Gorgoniidae) | 1421 | ||
2.11.1 Introduction | 1421 | ||
2.11.2 Natural Products from Pseudopterogorgia spp. | 1425 | ||
2.11.3 Aspects of Diterpenoid Biosynthesis and Chemical Ecology | 1466 | ||
2.11.4 Selected Synthetic Transformations Suggesting Plausible Biogenetic Relationships between Different Families of Pseudopterogorgia Diterpenes | 1470 | ||
2.11.5 Summary and Conclusions | 1473 | ||
Acknowledgments | 1479 | ||
Abbreviations | 1479 | ||
References | 1480 | ||
2.12 Exploiting Genomics for New Natural Product Discovery in Prokaryotes | 1487 | ||
2.12.1 Introduction | 1487 | ||
2.12.2 Overview of the Genetics and Enzymology of Natural Product Biosynthesis | 1488 | ||
2.12.3 Development of Bioinformatics Tools for Natural Product Discovery by Genome Mining | 1492 | ||
2.12.4 Experimental Strategies for the Isolation of New Natural Products by Genome Mining | 1500 | ||
2.12.5 Concluding Remarks | 1507 | ||
Abbreviations | 1509 | ||
References | 1509 | ||
2.13 Unlocking Environmental DNA Derived Gene Clusters Using a Metagenomics Approach | 1513 | ||
2.13.1 Introduction | 1513 | ||
2.13.2 Methodologies | 1515 | ||
2.13.3 Type II PKS KS from Soil Multigenomic DNA | 1518 | ||
2.13.4 Molecules and Their Biosynthetic Genes Isolated from Metagenomic Libraries | 1520 | ||
2.13.5 Conclusions | 1528 | ||
References | 1529 | ||
2.14 The Chemistry of Symbiotic Interactions | 1533 | ||
2.14.1 Introduction | 1533 | ||
2.14.2 Protists | 1534 | ||
2.14.3 Brown Algae | 1535 | ||
2.14.4 Green Plants | 1535 | ||
2.14.5 Fungi | 1544 | ||
2.14.6 Sponges | 1546 | ||
2.14.7 Cnidarians | 1550 | ||
2.14.8 Arthropods | 1553 | ||
2.14.9 Nematodes | 1557 | ||
2.14.10 Flatworms | 1558 | ||
2.14.11 Bryozoans | 1558 | ||
2.14.12 Molluscs | 1559 | ||
2.14.13 Tunicates | 1559 | ||
2.14.14 Conclusions | 1562 | ||
Abbreviations | 1562 | ||
References | 1563 | ||
2.15 Natural Peptide Toxins | 1569 | ||
2.15.1 Introduction | 1569 | ||
2.15.2 Cone Snails: Distribution, Diversity, Behavior, Feeding, and Defense | 1570 | ||
2.15.3 Molecular Diversity of Cone Snail Venom | 1571 | ||
2.15.4 Neuropharmacology of Cone Snail Toxins | 1575 | ||
2.15.5 Structure and Activity of Cone Snail Toxins | 1580 | ||
2.15.6 Cone Snail Toxins as Therapeutics and Drug Leads | 1581 | ||
2.15.7 Sea Anemones: Distribution, Diversity, Behavior, Feeding, and Defense | 1584 | ||
2.15.8 Sea Anemone Venom | 1585 | ||
2.15.9 Structure and Activity of Sea Anemone Toxins | 1586 | ||
2.15.10 Sea Anemone Toxins as Insecticides | 1589 | ||
2.15.11 Conclusions | 1590 | ||
References | 1591 | ||
2.16 Cyanobactins – Ubiquitous Cyanobacterial Ribosomal Peptide Metabolites | 1597 | ||
2.16.1 Introduction | 1597 | ||
2.16.2 Cyanobactin Structures | 1597 | ||
2.16.3 Sources and Symbiosis | 1599 | ||
2.16.4 Shape and Metal Binding | 1603 | ||
2.16.5 Bioactivity | 1605 | ||
2.16.6 Total Synthesis | 1606 | ||
2.16.7 Biosynthesis | 1606 | ||
2.16.8 Ecology and Purpose | 1610 | ||
2.16.9 Genome Mining and Modification | 1611 | ||
2.16.10 Summary and Conclusions | 1612 | ||
Acknowledgment | 1612 | ||
References | 1612 | ||
2.17 The Role of Synthesis and Biosynthetic Logic | 1617 | ||
2.17.1 Introduction | 1617 | ||
2.17.2 Chemoenzymatic Approaches to Pikromycin Synthesis | 1619 | ||
2.17.3 Chemoenzymatic Approaches to Tyrocidine Synthesis | 1624 | ||
2.17.4 Chemoenzymatic Approaches to Cryptophycin Synthesis | 1628 | ||
2.17.5 Conclusions | 1633 | ||
Abbreviations | 1634 | ||
References | 1634 | ||
2.18 Missasigned Structures: Case Examples from the Past Decade | 1639 | ||
2.18.1 Introduction | 1639 | ||
2.18.2 Structure Diversity of Marine Natural Products | 1643 | ||
2.18.3 Misassigned Marine Natural Products | 1643 | ||
2.18.4 Difficulties of Molecular Formula Assignments | 1643 | ||
2.18.5 Difficulties in Assembling Planar Structures | 1661 | ||
2.18.6 Completion of Structure Elucidation | 1673 | ||
2.18.7 Conclusions | 1676 | ||
Abbreviations | 1676 | ||
References | 1676 | ||
2.19 Natural Products of Therapeutic Importance | 1681 | ||
2.19.1 Introduction | 1681 | ||
2.19.2 Anti-infectives | 1682 | ||
2.19.3 Anticholestemics | 1694 | ||
2.19.4 Microbial Products in Cancer | 1697 | ||
2.19.5 Nonmicrobial Products in Cancer | 1702 | ||
2.19.6 Summary and Future Prospects | 1703 | ||
References | 1704 | ||
2.20 Natural Products as Probes of Selected Targets in Tumor Cell Biology and Hypoxic Signaling | 1709 | ||
2.20.1 Introduction | 1709 | ||
2.20.2 Organelle Function and Protein Stability | 1711 | ||
2.20.3 Oxygen-Regulated Cell Signaling – Interactions between Cellular Processes | 1731 | ||
2.20.4 Conclusions and Future Directions | 1736 | ||
Acknowledgments | 1736 | ||
References | 1736 | ||
e9780080453811v3 | 1743 | ||
Cover | 1743 | ||
Title page | 1746 | ||
Copyright page | 1747 | ||
Contents | 1748 | ||
Contributors | 1750 | ||
Preface | 1754 | ||
Introduction | 1756 | ||
Editors in Chief | 1760 | ||
Volume Editors | 1762 | ||
3.01 Overview and Introduction | 1768 | ||
3.01.1 Biodiversity and Chemodiversity | 1768 | ||
3.01.2 Biodiscovery | 1769 | ||
3.01.3 Traditional Knowledge | 1769 | ||
3.01.4 Food and Health | 1769 | ||
3.01.5 Supply of Natural Products | 1770 | ||
3.01.6 Chemistry of Some Common Plants and Related Products | 1770 | ||
3.01.7 Model Plant and the Future | 1770 | ||
References | 1771 | ||
3.02 Natural Products as Lead Sources for Drug Development | 1772 | ||
3.02.1 Introduction – A Historical Perspective | 1772 | ||
3.02.2 Natural Product Properties | 1776 | ||
3.02.3 Chemical Space | 1781 | ||
3.02.4 Natural Product-Based Libraries | 1786 | ||
3.02.5 Natural Product Drug Development | 1794 | ||
3.02.6 Natural Products as Source for Leads and Clinical Candidates | 1800 | ||
3.02.7 Conclusion and Outlook | 1805 | ||
References | 1807 | ||
3.03 Topical Chemical Space Relation to Biological Space | 1814 | ||
3.03.1 Introduction | 1814 | ||
3.03.2 Chemical Space | 1816 | ||
3.03.3 Biological Space | 1826 | ||
3.03.4 Comparing Chemical and Biological Space | 1833 | ||
3.03.5 Examples of Studies Pursued | 1835 | ||
3.03.6 Conclusions and Future Prospects | 1842 | ||
Acknowledgments | 1843 | ||
References | 1843 | ||
3.04 The NAPRALERT Database as an Aid for Discovery of Novel Bioactive Compounds | 1848 | ||
3.04.1 Introduction | 1848 | ||
3.04.2 Relational Search Strategies | 1855 | ||
3.04.3 Summary and Future Prospects | 1857 | ||
3.04.4 NAPRALERT in Perspective | 1860 | ||
References | 1860 | ||
3.05 Plant Diversity from Brazilian Cerrado and Atlantic Forest as a Tool for Prospecting Potential Therapeutic Drugs | 1862 | ||
3.05.1 Introduction | 1862 | ||
3.05.2 Main Biomes of Brazil | 1865 | ||
3.05.3 Development of the Brazilian Natural Products Chemistry | 1868 | ||
3.05.4 Exploring New Approaches for Natural Product Drug Discovery in the Biota/FAPESP: Current Status of Bioprospecting in Brazil | 1875 | ||
3.05.5 Search for Bioactive Secondary Metabolites from Brazilian Plant Species | 1876 | ||
3.05.6 Final Remarks and Conclusions | 1895 | ||
References | 1896 | ||
3.06 Nature as Source of Medicines; Novel Drugs from Nature; Screening for Antitumor Activity | 1902 | ||
3.06.1 Introduction | 1903 | ||
3.06.2 Nature’s Continuing Role in Drug Discovery | 1904 | ||
3.06.3 Why Nature? | 1904 | ||
3.06.4 Nature as a Source of Molecular and Mechanistic Diversity in Cancer Chemotherapy | 1915 | ||
3.06.5 Summary and Future Prospects | 1934 | ||
References | 1934 | ||
3.07 The Identification of Bioactive Natural Products by High Throughput Screening (HTS) | 1944 | ||
3.07.1 Introduction | 1944 | ||
3.07.2 Biota Collection | 1945 | ||
3.07.3 Preparation of Natural Product Extracts for High-Throughput Screening | 1946 | ||
3.07.4 Logistics | 1947 | ||
3.07.5 Preparation of Plates for High-Throughput Screening | 1947 | ||
3.07.6 High-Throughput Screening | 1948 | ||
3.07.7 The Target | 1948 | ||
3.07.8 The Assay | 1948 | ||
3.07.9 Essential Components for a Good HTS Assay | 1949 | ||
3.07.10 Technology | 1950 | ||
3.07.11 High-Content Screening | 1952 | ||
3.07.12 Natural Product High-Throughput Screening | 1953 | ||
3.07.13 Isolation of Bioactive Natural Products | 1955 | ||
3.07.14 Small-Scale Bioprofiling | 1957 | ||
3.07.15 Scale-Up Purification | 1958 | ||
3.07.16 Structure Determination | 1959 | ||
3.07.17 Automated Structure Determination | 1962 | ||
3.07.18 Converting a Natural Product Hit into a Drug | 1962 | ||
References | 1965 | ||
3.08 Natural Products Drug Discovery | 1972 | ||
3.08.1 Introduction | 1972 | ||
3.08.2 The Current Pharmaceutical Scenario | 1973 | ||
3.08.3 Why Natural Products Are Intrinsically Useful for Drug Discovery | 1974 | ||
3.08.4 Possible Reasons for the Current Downsizing of Natural Discovery | 1981 | ||
3.08.5 Strategies in Natural Products Drug Discovery | 1990 | ||
3.08.6 Conclusions | 1998 | ||
References | 1999 | ||
3.09 Natural Product-Based Biopesticides for Insect Control | 2004 | ||
3.09.1 Introduction | 2004 | ||
3.09.2 Commercial Insecticides of Plant Origin | 2006 | ||
3.09.3 New Insecticide Sources | 2011 | ||
3.09.4 Sustainable Production: Culture Methods | 2026 | ||
3.09.5 The New Biopesticide Market | 2028 | ||
3.09.6 Conclusions | 2029 | ||
Abbreviations | 2029 | ||
3.10 Natural Products as Sweeteners and Sweetness Modifiers | 2036 | ||
3.10.1 Introduction | 2036 | ||
3.10.2 Commercially Used Highly Sweet Natural Products | 2037 | ||
3.10.3 Discovery of Natural Sweeteners | 2041 | ||
3.10.4 Structural Types of Highly Sweet Natural Products | 2043 | ||
3.10.5 Naturally Occurring Sweetness Inducers | 2063 | ||
3.10.6 Naturally Occurring Triterpenoid Sweetness Inhibitors | 2065 | ||
3.10.7 Sensory Evaluation of Natural Products for Sweetness and Sweetness-Modifying Properties | 2071 | ||
3.10.8 Interactions of Natural Products at the Sweet Receptor | 2073 | ||
3.10.9 Conclusions | 2074 | ||
Abbreviations | 2075 | ||
References | 2076 | ||
3.11 Chemistry of Cosmetics | 2084 | ||
3.11.1 Introduction | 2084 | ||
3.11.2 History of Cosmetics and Natural Products | 2084 | ||
3.11.3 Pharmaceutical Affairs Law in Japan and Its Relevance to Natural Products | 2086 | ||
3.11.4 Skin-Whitening Cosmetics | 2089 | ||
3.11.5 Antiaging Cosmetics | 2094 | ||
3.11.6 Hair Growth Promoters | 2100 | ||
3.11.7 Plant Cell/Tissue Culture Technology for Natural Produ 3.11.7 Plant Cell/Tissue Culture Technology for Natural Products in cosmeticcs\r | 2104 | ||
3.11.8 Conclusion | 2113 | ||
Abbreviations | 2113 | ||
References | 2114 | ||
3.12 Ethnopharmacology and Drug Discovery | 2118 | ||
3.12.1 Introduction | 2118 | ||
3.12.2 ‘Old’ Drugs – New Medicines | 2119 | ||
3.12.3 Today’s Core Challenges | 2141 | ||
3.12.4 Conclusion: People, Plants, and the Future of Medicines | 2143 | ||
Abbreviations | 2144 | ||
References | 2144 | ||
3.13 Chinese Traditional Medicine | 2150 | ||
3.13.1 Introduction | 2150 | ||
3.13.2 Radix et Rhizoma Notoginseng (Sanqi, Tianqi, or Sanchi) | 2154 | ||
3.13.3 Radix et Rhizoma Salviae Miltiorrhizae (Danshen) | 2154 | ||
3.13.4 Ganoderma (Lingzhi) | 2165 | ||
3.13.5 Radix et Rhizoma Glycyrrhizae (Licorice, Gancao) | 2169 | ||
3.13.6 Herba Epimedii (Yinyanghuo) | 2177 | ||
3.13.7 Flos Carthami (Honghua) | 2177 | ||
3.13.8 Radix Isatidis (Banlangen) | 2177 | ||
3.13.9 Radix Astragali (Huangqi) | 2219 | ||
3.13.10 Herba Cistanches (Roucongrong) | 2219 | ||
3.13.11 Gamboge (Tenghuang) | 2219 | ||
3.13.12 Conclusion | 2226 | ||
Glossary | 2232 | ||
Abbreviation | 2232 | ||
References | 2232 | ||
3.14 Ayurveda in Modern Medicine: Development and Modification of Bioactivity | 2246 | ||
3.14.1 Introduction | 2246 | ||
3.14.2 Plant-Based Pharmaceuticals from Ayurveda | 2248 | ||
3.14.3 Techniques for Development of Bioactivity of Ayurvedic Medicines | 2258 | ||
3.14.4 Further Development from Phytochemical Leads | 2261 | ||
3.14.5 Formulation in Ayurveda and Its Value Addition | 2262 | ||
3.14.6 Quality Control | 2265 | ||
3.14.7 Safety of Ayurvedic Preparations | 2267 | ||
3.14.8 Ongoing Research in India on Ayurveda | 2268 | ||
3.14.9 Conclusion | 2268 | ||
Acknowledgment | 2271 | ||
Abbreviations | 2271 | ||
References | 2271 | ||
3.15 Biologically Active Compounds in Food Products and Their Effects on Obesity and Diabetes | 2276 | ||
3.15.1 Introduction | 2277 | ||
3.15.2 Some Basic Aspects of Food Composition | 2278 | ||
3.15.3 The Regulatory Categories Conventional Foods, Functional Foods,and Dietary Supplements | 2279 | ||
3.15.4 Obesity: From Prevention to Metabolic Complications | 2281 | ||
3.15.5 Natural Compounds in Weight Management and Diabetes – Introduction and Classification | 2287 | ||
3.15.6 Natural Compounds and Preparations for Appetite Regulation | 2288 | ||
3.15.7 Natural Compounds and Preparations Claiming to Affect Fat Absorption | 2294 | ||
3.15.8 Natural Compounds Affecting Lipid Metabolism or Energy Expenditure | 2295 | ||
3.15.9 Natural Compounds in Type 2 Diabetes | 2298 | ||
3.15.10 Nutrigenomics – Finding Effects, Pathways, and New Molecules | 2303 | ||
3.15.11 Conclusions | 2306 | ||
Abbreviations | 2306 | ||
References | 2307 | ||
3.16 Chemistry of Flavonoid-Based Colors in Plants | 2314 | ||
3.16.1 Introduction | 2315 | ||
3.16.2 Color Variation Owing to Anthocyanin Structure | 2322 | ||
3.16.3 Anthocyanin Localization in Plant Tissue | 2347 | ||
3.16.4 Colors of Aurones and Chalcones | 2349 | ||
3.16.5 Biosynthesis of Flavonoids | 2355 | ||
3.16.6 Functions of Flavonoid Pigments in Plants | 2358 | ||
3.16.7 Anthocyanin Production | 2367 | ||
Glossary | 2370 | ||
References | 2371 | ||
3.17 Production of Pharmaceuticals by Plant Tissue Cultures | 2382 | ||
3.17.1 Introduction | 2382 | ||
3.17.2 Methods of Plant Tissue Culture | 2383 | ||
3.17.3 Production of Pharmaceuticals by Plant Tissue Culture | 2388 | ||
3.17.4 Perspectives | 2391 | ||
Abbreviations | 2391 | ||
References | 2391 | ||
3.18 Plant Secondary Metabolism Engineering: Methods, Strategies, Advances, and Omics | 2396 | ||
3.18.1 Introduction | 2396 | ||
3.18.2 Techniques for the Genetic Manipulation of Plants | 2399 | ||
3.18.3 Strategies for the Genetic Engineering of Secondary Metabolic Pathways | 2401 | ||
3.18.4 Metabolic Engineering of Plant Biosynthetic Networks | 2408 | ||
3.18.5 Influences of Omics Technologies on Metabolic Engineering of Plants | 2425 | ||
3.18.6 Future Directions | 2428 | ||
Acknowledgments | 2429 | ||
References | 2429 | ||
3.19 Biotransformation of Monoterpenoids | 2436 | ||
3.19.1 Introduction | 2436 | ||
3.19.2 Metabolic Pathways of Monoterpenoids | 2437 | ||
3.19.3 Mosquitocidal and Knockdown Activity | 2556 | ||
3.19.4 Antimicrobial Activity | 2556 | ||
3.19.5 Microbial Transformation of Terpenoids as Unit Reaction | 2557 | ||
References | 2560 | ||
3.20 Biotransformation of Sesquiterpenoids | 2570 | ||
3.20.1 Introduction | 2570 | ||
3.20.2 Biotransformation of Sesquiterpenoids by Microorganisms | 2570 | ||
3.20.3 Biotransformation of Sesquiterpenoids by Mammals, Insects, and Cytochrome P-450 | 2648 | ||
References | 2654 | ||
3.21 Biotransformation of Di- and Triterpenoids, Steroids, and Miscellaneous Synthetic Substrates | 2660 | ||
3.21.1 Biotransformation of Di- and Triterpenoids and Steroids | 2660 | ||
3.21.2 Biotransformation of Ionones, Damascones, and Adamantanes | 2682 | ||
3.21.3 Biotransformation of Aromatic Compounds | 2690 | ||
3.21.4 Biotransformation of Cyclohexane Derivatives and Other Selected Synthetic Compounds by Microorganisms | 2713 | ||
Acknowledgments | 2728 | ||
References | 2728 | ||
3.22 Beer Flavor | 2734 | ||
3.22.1 Introduction | 2735 | ||
3.22.2 Hop Chemistry | 2741 | ||
3.22.3 Hop Processing | 2751 | ||
3.22.4 Beer Flavors and Off-Flavors | 2753 | ||
3.22.5 Beer Flavor Deterioration | 2758 | ||
3.22.6 Microbiological Deterioration | 2761 | ||
3.22.7 Prospects | 2761 | ||
Acknowledgments | 2761 | ||
References | 2761 | ||
3.23 Chemistry of Tea | 2766 | ||
3.23.1 Introduction | 2767 | ||
3.23.2 Manufacture of Tea | 2767 | ||
3.23.3 Constituents of Tea and Chemical Reactions during Manufacture | 2769 | ||
3.23.4 Extraction and Storage of Tea | 2786 | ||
3.23.5 Products | 2788 | ||
3.23.6 Potential Health Effects of Tea, Its Flavonoids, and Theanine | 2788 | ||
3.23.7 Analytical Section | 2791 | ||
Abbreviations | 2793 | ||
Nomenclature | 2794 | ||
References | 2794 | ||
3.24 Chemistry of Cannabis | 2800 | ||
3.24.1 An Introduction to the Cannabis Plant | 2801 | ||
3.24.2 Cannabinoids | 2806 | ||
3.24.3 Sites and Mechanisms of Action of Cannabinoids | 2816 | ||
3.24.4 Biological Effects of the Cannabinoids | 2822 | ||
3.24.5 Noncannabinoid Constituents of Cannabis | 2827 | ||
3.24.6 Cannabis as a Medicine | 2835 | ||
3.24.7 Practical Aspects of Cannabis Research | 2839 | ||
3.24.8 Conclusion | 2841 | ||
Acknowledgements | 2844 | ||
References | 2844 | ||
3.25 Chemistry of Coffee | 2852 | ||
3.25.1 Overview | 2852 | ||
3.25.2 Botany | 2856 | ||
3.25.3 Chemistry Components and Processes | 2861 | ||
3.25.4 Conclusions | 2880 | ||
3.26 Chemistry of Wine | 2886 | ||
3.26.2 Chemistry Associated with Wine Fermentations | 2888 | ||
3.26.3 Chemistry of Aroma Compounds in Wine | 2893 | ||
3.26.4 Chemistry of Phenolic Compounds in Wine | 2901 | ||
3.26.5 Conclusion and Future Prospects | 2930 | ||
Abbreviations | 2930 | ||
Nomenclature | 2931 | ||
References | 2931 | ||
3.27 Trees: A Remarkable Biochemical Bounty | 2940 | ||
3.27.1 Trees: Human Reliance on Arborescent Life | 2941 | ||
3.27.2 Evolution of the Woody Growth Habit: Land Colonization and Adaptation | 2945 | ||
3.27.3 Wood Anatomy and Cellular/Tissue Function: The Living and the Dead | 2958 | ||
3.27.4 Nature’s Phytochemical Bounty and Tree Biochemical Diversity | 2994 | ||
3.27.5 Concluding Remarks | 3049 | ||
Acknowledgments | 3051 | ||
References | 3051 | ||
3.28 The Chemistry of Arabidopsis thaliana | 3064 | ||
3.28.1 Introduction | 3064 | ||
3.28.2 Secondary Metabolites of Arabidopsis thaliana | 3066 | ||
3.28.3 Ecological Roles of Secondary Metabolites of Arabidopsis thaliana | 3074 | ||
3.28.4 Conclusions | 3078 | ||
References | 3079 | ||
e9780080453811v4 | 3084 | ||
Cover | 3084 | ||
Title Page | 3087 | ||
Copyright Page | 3088 | ||
Contents | 3089 | ||
Contributors | 3091 | ||
Preface | 3095 | ||
Introduction | 3097 | ||
Editors in Chief | 3101 | ||
Volume Editors | 3103 | ||
4.01 Overview and Introduction | 3109 | ||
4.01.1 Scope of Volume 4 | 3109 | ||
4.01.2 Comments on Progress in the Chemistry and Biology of Semiochemicals | 3109 | ||
4.01.3 Future Perspectives in Chemical Ecology | 3114 | ||
Acknowledgments | 3114 | ||
Glossary | 3114 | ||
References | 3114 | ||
4.02 Plant Hormones | 3117 | ||
4.02.1 Introduction | 3120 | ||
4.02.2 Auxins | 3121 | ||
4.02.3 Gibberellins | 3132 | ||
4.02.4 Cytokinins | 3145 | ||
4.02.5 Abscisic Acid | 3161 | ||
4.02.6 Brassinosteroids | 3175 | ||
4.02.7 Jasmonates and Oxylipins | 3185 | ||
4.02.8 Ethylene | 3195 | ||
4.02.9 Peptide Hormones in Plants | 3199 | ||
4.02.10 Strigolactones | 3204 | ||
References | 3208 | ||
4.03 Insect Hormones | 3235 | ||
4.03.1 Introduction | 3235 | ||
4.03.2 Neuropeptides | 3236 | ||
4.03.3 Moulting Hormone | 3236 | ||
4.03.4 Juvenile Hormone | 3247 | ||
4.03.5 Eicosanoids | 3253 | ||
4.03.6 Conclusion | 3255 | ||
Glossary | 3255 | ||
References | 3256 | ||
4.04 Pheromones of Terrestrial Invertebrates | 3261 | ||
4.04.1 Introduction | 3262 | ||
4.04.2 Pheromone Biology | 3262 | ||
4.04.3 Isolation and Structure Elucidation | 3264 | ||
4.04.4 Aromatic Compounds | 3267 | ||
4.04.5 Unbranched Aliphatic Compounds | 3271 | ||
4.04.6 Terpenes | 3291 | ||
4.04.7 Propanogenins and Related Compounds | 3304 | ||
4.04.8 Mixed Structures | 3308 | ||
4.04.9 Other Structures | 3313 | ||
References | 3315 | ||
4.05 Pheromones in Vertebrates | 3333 | ||
4.05.1 Introduction | 3334 | ||
4.05.2 Pheromones in Ancient Vertebrates | 3338 | ||
4.05.3 Pheromones in Advanced (Teleost) Fishes | 3342 | ||
4.05.4 Pheromones in Amphibians | 3348 | ||
4.05.5 Pheromones in Reptiles | 3352 | ||
4.05.6 Pheromones in Birds | 3353 | ||
4.05.7 Pheromones in Mammals | 3354 | ||
4.05.8 Overview | 3365 | ||
References | 3366 | ||
4.06 Pheromones of Marine Invertebrates and Algae | 3371 | ||
4.06.1 Introduction | 3371 | ||
4.06.2 Algal Sex Pheromones | 3371 | ||
4.06.3 Sperm Chemotaxis in Marine Invertebrates | 3376 | ||
4.06.4 Sex Pheromones of Marine Invertebrates | 3381 | ||
4.06.5 Alarm Pheromones | 3384 | ||
4.06.6 Summary and Future Prospects | 3385 | ||
References | 3386 | ||
4.07 Cell-to-Cell Communications among Microorganisms | 3391 | ||
4.07.1 Introduction | 3392 | ||
4.07.2 Gamma-Butyrolactones in Streptomyces | 3393 | ||
4.07.3 Signaling Molecules in High-GC Gram-Positive Bacteria | 3403 | ||
4.07.4 Signaling Molecules in Low-GC Gram-Positive Bacteria | 3406 | ||
4.07.5 Signaling Molecules in Gram-Negative Bacteria | 3423 | ||
References | 3438 | ||
4.08 Chemical Defence and Toxins of Plants | 3447 | ||
4.08.1 Chemical Defense against Herbivores | 3447 | ||
4.08.2 Antimicrobial Chemical Defense | 3469 | ||
4.08.3 Phytotoxins | 3479 | ||
References | 3485 | ||
4.09 Chemical Defense and Toxins of Lower Terrestrial and Freshwater Animals | 3495 | ||
4.09.1 Introduction | 3495 | ||
4.09.2 Alveolata | 3496 | ||
4.09.3 Porifera | 3498 | ||
4.09.4 Cnidaria | 3498 | ||
4.09.5 Platyhelminthes (Flatworms) | 3499 | ||
4.09.6 Nemathelminthes: Nematoda | 3499 | ||
4.09.7 Rotatoria (Rotifers) | 3499 | ||
4.09.8 Nemertini | 3499 | ||
4.09.9 Mollusca | 3500 | ||
4.09.10 Annelida: Clitellata: Oligochaeta | 3501 | ||
4.09.11 Annelida: Clitellata: Hirudinea | 3502 | ||
4.09.12 Arthropoda: Onychophora | 3502 | ||
4.09.13 Arthropoda: Tardigrada | 3503 | ||
4.09.14 Arthropoda: Crustacea, Ostracoda | 3503 | ||
4.09.15 Arthropoda: Crustacea, Decapoda | 3503 | ||
4.09.16 Arthropoda: Crustacea, Amphipoda | 3503 | ||
4.09.17 Arthropoda: Crustacea, Isopoda | 3503 | ||
4.09.18 Arthropoda: Chelicerata, Scorpiones | 3504 | ||
4.09.19 Arthropoda: Chelicerata, Pseudoscorpiones | 3504 | ||
4.09.20 Arthropoda: Chelicerata, Acari (Mites) | 3504 | ||
4.09.21 Arthropoda: Chelicerata, Opiliones | 3506 | ||
4.09.22 Arthropoda: Chelicerata, Pedipalpi | 3508 | ||
4.09.23 Arthropoda: Chelicerata, Araneae | 3509 | ||
4.09.24 Arthropoda: Myriapoda: Opisthogoneata (Centipedes) | 3510 | ||
4.09.25 Arthropoda: Myriapoda: Progoneata: Diplopoda (Millipedes) and Symphyla | 3511 | ||
Acknowledgments | 3514 | ||
References | 3515 | ||
4.10 Toxins of Microorganisms | 3519 | ||
4.10.1 Introduction | 3519 | ||
4.10.2 Insecticides from Microorganisms | 3520 | ||
4.10.3 Mycotoxins | 3527 | ||
References | 3557 | ||
4.11 Terrestrial Natural Products as Antifeedants | 3565 | ||
4.11.1 Introduction | 3565 | ||
4.11.2 Bioassays | 3566 | ||
4.11.3 Plant Terpenes and Derivatives | 3568 | ||
4.11.4 Alkaloids | 3597 | ||
4.11.5 Phenylpropanoids | 3598 | ||
4.11.6 Miscellaneous | 3603 | ||
4.11.7 Feeding Deterrence in Higher Animals | 3604 | ||
4.11.8 Conclusion | 3605 | ||
References | 3605 | ||
4.12 Marine Natural Products as Antifeedants | 3611 | ||
4.12.1 Introduction | 3611 | ||
4.12.2 Microorganisms | 3613 | ||
4.12.3 Algae | 3615 | ||
4.12.4 Sponges | 3618 | ||
4.12.5 Coelenterates | 3625 | ||
4.12.6 Ascidians | 3629 | ||
4.12.7 Bryozoans | 3631 | ||
4.12.8 Mollusks | 3632 | ||
4.12.9 Other Marine Organisms | 3640 | ||
4.12.10 Conclusions | 3641 | ||
References | 3641 | ||
4.13 Allelochemicals for Plant–Plant and Plant–Microbe Interactions | 3647 | ||
4.13.1 Allelochemicals in Plant–Plant Interactions | 3647 | ||
4.13.2 Allelochemicals in Plant–Microbe Interactions | 3655 | ||
References | 3666 | ||
4.14 Allelochemicals in Plant–Insect Interactions | 3671 | ||
4.14.1 Introduction | 3671 | ||
4.14.2 Host Selection | 3672 | ||
4.14.3 Flower-Visiting and Foraging | 3688 | ||
4.14.4 Insect–Plant Interface in Multitrophic Interactions | 3693 | ||
References | 3698 | ||
4.15 Human–Environment Interactions (1): Flavor and Fragrance | 3703 | ||
4.15.1 Introduction | 3704 | ||
4.15.2 Outline of the Flavor and Fragrance Industry | 3704 | ||
4.15.3 Analytical Techniques | 3709 | ||
4.15.4 Flavor and Fragrance of Natural Origin | 3713 | ||
4.15.5 Perfumery (Fragrances) | 3720 | ||
4.15.6 Flavor of Foodstuffs | 3721 | ||
4.15.7 Human Interactions | 3726 | ||
4.15.8 Outlook | 3730 | ||
Abbreviations | 3731 | ||
Nomenclature | 3731 | ||
References | 3731 | ||
4.16 Human–Environment Interactions – Taste | 3739 | ||
4.16.1 Introduction | 3740 | ||
4.16.2 Natural Products Associated with Sweetness | 3741 | ||
4.16.3 Bitter-Tasting Natural Products | 3752 | ||
4.16.4 Pungent Natural Products | 3760 | ||
4.16.5 Astringent Natural Products | 3764 | ||
4.16.6 Umami and Kokumi | 3767 | ||
4.16.7 Sour and Salty Tastes | 3770 | ||
4.16.8 Conclusion | 3772 | ||
References | 3772 | ||
e9780080453811v5 | 3781 | ||
Cover | 3781 | ||
Title Page | 3784 | ||
Copyright Page | 3785 | ||
Contents | 3786 | ||
Contributors | 3788 | ||
Preface | 3792 | ||
Introduction | 3794 | ||
Editors in Chief | 3798 | ||
Volume Editors | 3800 | ||
5.01 Overview and Introduction | 3806 | ||
5.02 Nonprotein L-Amino Acids | 3810 | ||
5.02.1 Introduction | 3810 | ||
5.02.2 Biosynthesis of Amino Acids | 3811 | ||
5.02.3 Classification of Nonprotein Amino Acids | 3817 | ||
Abbreviations | 3868 | ||
References | 3869 | ||
5.03 Novel Enzymes for Biotransformation and Resolution of Alpha-Amino Acids | 3876 | ||
5.03.1 Introduction | 3877 | ||
5.03.2 Amino Acid Oxidases | 3877 | ||
5.03.3 Amino Acid Dehydrogenases | 3881 | ||
5.03.4 Aminotransferases | 3885 | ||
5.03.5 Lipases, Acylases, and Proteinases | 3887 | ||
5.03.6 L-Amino Acid N-Acylases | 3889 | ||
5.03.7 Hydantoinases and Carbamoylases | 3890 | ||
5.03.8 Nitrilases, Nitrile Hydratases, and Amidases | 3891 | ||
5.03.9 Concluding Remarks | 3892 | ||
Nomenclature | 3892 | ||
References | 3893 | ||
5.04 1-Aminocyclopropane-1-Carboxylate Synthase, an Enzyme of Ethylene Biosynthesis | 3896 | ||
5.04.1 Introduction | 3896 | ||
5.04.2 Ethylene Biosynthesis in Higher Plants | 3897 | ||
5.04.3 Ethylene Signal Transduction Pathway | 3912 | ||
5.04.4 Ethylene Action | 3915 | ||
Abbreviations | 3920 | ||
References | 3921 | ||
5.05 Specific and Nonspecific Incorporation of Selenium into Macromolecules | 3926 | ||
5.05.1 Introduction | 3926 | ||
5.05.2 Nonspecific Incorporation of Selenium into Macromolecules | 3928 | ||
5.05.3 Specific Utilization of Selenium in Biology | 3932 | ||
5.05.4 Summary | 3947 | ||
Abbreviations | 3947 | ||
References | 3948 | ||
5.06 Protein Toxins from Bacteria | 3954 | ||
5.06.1 Introduction: Bacterial Toxins – An Overview | 3954 | ||
5.06.2 Potent Virulence Factors Directly Attack the Actin Cytoskeleton of Mammalian Cells: Actin-ADP-Ribosylating Toxins | 3958 | ||
5.06.3 Introduction of a ‘Super’ Microbe | 3963 | ||
5.06.4 Structural Commonalities/Differences among SEs and TSST-1 | 3965 | ||
5.06.5 Signal Transduction and Cell Responses Induced by SEs and TSST-1 | 3968 | ||
5.06.6 Animal Models: Surprise, Mice are Not Men! | 3970 | ||
5.06.7 Strategic Countermeasures: An Eternal Battle between Man and Microbe | 3971 | ||
5.06.8 Conclusions | 3972 | ||
Abbreviations | 3973 | ||
References | 3973 | ||
5.07 Host Defense Peptides: Bridging Antimicrobial and Immunomodulatory Activities | 3980 | ||
5.07.1 Introduction | 3981 | ||
5.07.2 Defining Cationic Host Defense Peptides | 3981 | ||
5.07.3 Host Defense Peptides Distribution and Class | 3983 | ||
5.07.4 Host Defense Peptide Target Selection and Self-Promoted Uptake | 3987 | ||
5.07.5 Host Defense Peptides and Cell Death | 3992 | ||
5.07.6 Structure–Activity Relationship Studies of the Antimicrobial Activities of the Host Defense Peptides | 3992 | ||
5.07.7 Bacterial Host Defense Peptide Resistance | 3994 | ||
5.07.8 Direct Antimicrobial Activity of Host Defense Peptides In Vivo | 3996 | ||
5.07.9 The Role of Peptides in Mammalian Immunity – The In Vivo Evidence | 3997 | ||
5.07.10 Immunomodulatory Activities of Host Defense Peptides | 3998 | ||
5.07.11 Host Defense Peptides and the Adaptive Immune Response | 4003 | ||
5.07.12 Structure–Activity Relationship Studies of Host Defense Peptides – Immunomodulatory Activities | 4004 | ||
5.07.13 Therapeutic Applications of Host Defense Peptides | 4005 | ||
5.07.14 Strategies for Host Defense Peptide Selection and Optimization | 4009 | ||
5.07.15 Conclusions | 4011 | ||
Abbreviations | 4013 | ||
References | 4014 | ||
5.08 Biosynthesis and Mode of Action of Lantibiotics | 4022 | ||
5.08.1 Introduction | 4022 | ||
5.08.2 Overview of Lantibiotic Structures | 4025 | ||
5.08.3 Lantibiotic Biosynthesis | 4026 | ||
5.08.4 Biological Activities of Lantibiotics | 4046 | ||
5.08.5 Potential Applications of Lantibiotics | 4050 | ||
5.08.6 Lantibiotic Engineering and Structure–Activity Studies | 4050 | ||
5.08.7 Outlook | 4053 | ||
Abbreviations | 4053 | ||
References | 4054 | ||
5.09 Plant Peptide Toxins from Nonmarine Environments | 4062 | ||
5.09.1 Introduction | 4062 | ||
5.09.2 Plant Defense Peptides | 4064 | ||
5.09.3 Plant Peptide Toxins in Biotechnology and Pharmaceutical Applications | 4083 | ||
5.09.4 Concluding Remarks | 4085 | ||
References | 4085 | ||
5.10 Therapeutic Value of Peptides from Animal Venoms | 4092 | ||
5.10.1 Introduction | 4092 | ||
5.10.2 Peptides from Scorpion Venoms | 4092 | ||
5.10.3 Peptides from Snake Venoms | 4095 | ||
5.10.4 Peptides from Sea Anemone Venoms | 4096 | ||
5.10.5 Peptides from Spider Venoms | 4097 | ||
5.10.6 Peptides from Cone Snail Venoms | 4099 | ||
5.10.7 Peptides from Insect Venoms | 4101 | ||
5.10.8 Peptides from Worm Venoms | 4102 | ||
5.10.9 Other Venom Peptides and Toxins of Interest | 4102 | ||
Abbreviations | 4103 | ||
References | 4104 | ||
5.11 Signal Transduction in Gram-Positive Bacteria by Bacterial Peptides | 4110 | ||
5.11.1 Introduction | 4110 | ||
5.11.2 Peptide Pheromone Dependent Signaling Systems in Bacteriocin Production | 4110 | ||
5.11.3 The Signaling Pathway of Plantaricin C11 System and Other Class II Bacteriocins | 4112 | ||
5.11.4 Peptide-Dependent Regulation of Lantibiotics | 4115 | ||
5.11.5 Induction of Competence for Natural Genetic Transformation in Streptococci | 4115 | ||
5.11.6 Virulence Regulation by Peptide Signaling in Staphylococcus aureus | 4117 | ||
5.11.7 Virulence Regulation in Enterococcus faecalis by Peptide Signaling | 4120 | ||
5.11.8 Peptide Signaling Regulation of Carbohydrate Metabolism in Lactobacillus plantarum | 4121 | ||
5.11.9 agr-Like Quorum Sensing Gene Clusters Identified in Other G+ Bacteria | 4121 | ||
5.11.10 Pheromone-Responding Conjugative Plasmids in Enterococcus faecalis | 4121 | ||
5.11.11 Perspectives | 4122 | ||
Abbreviations | 4123 | ||
References | 4123 | ||
5.12 A New Generation of Artificial Enzymes: Catalytic Antibodies or ‘Abzymes’ | 4128 | ||
5.12.1 Introduction | 4128 | ||
5.12.2 The Concept of Catalytic Antibodies or Abzymes | 4129 | ||
5.12.3 Catalytic Antibodies Generated against Transition State Analogues | 4130 | ||
5.12.4 ‘Bait and Switch’ Strategy | 4141 | ||
5.12.5 Reactive Immunization | 4142 | ||
5.12.6 Antibodies Using Cofactors | 4147 | ||
5.12.7 Anti-Idiotypic Antibodies | 4149 | ||
5.12.8 Other Approaches | 4151 | ||
5.12.9 Conclusion | 4152 | ||
References | 4154 | ||
5.13 Recent Progress on Understanding Ribosomal Protein Synthesis | 4158 | ||
5.13.1 Introduction | 4158 | ||
5.13.2 Ribosome Structure | 4161 | ||
5.13.3 Ribosomal Aminoacyl-tRNA Selection | 4164 | ||
5.13.4 Peptide Bond Formation | 4170 | ||
5.13.5 Translocation | 4174 | ||
5.13.6 Termination | 4177 | ||
5.13.7 Ribosomal Incorporation of Non-Natural Amino Acids | 4180 | ||
5.13.8 Conclusion | 4183 | ||
References | 4184 | ||
5.14 Glutaminyl-tRNA and Asparaginyl-tRNA Biosynthetic Pathways | 4188 | ||
5.14.1 Introduction | 4189 | ||
5.14.2 Nonenzymatic Deamidation of Glutaminyl and Asparaginyl Residues in Protein | 4192 | ||
5.14.3 Introduction of Glutamine to the Genetic Code | 4193 | ||
5.14.4 Partners of Direct and Indirect Pathways of Asn-tRNA Biosynthesis and their Reaction Mechanism | 4202 | ||
5.14.5 Evolution of the Enzymes Involved in Gln-tRNA and in Asn-tRNA Biosynthesis | 4219 | ||
5.14.6 Inhibitors of Enzymes Involved in Gln-tRNA and Asn-tRNA Biosynthesis as Tools for Structural and Mechanistic Studies and Leads for Therapeutic Applications | 4221 | ||
5.14.7 Conclusions | 4228 | ||
Abbreviations | 4228 | ||
Nomenclature | 4229 | ||
References | 4230 | ||
5.15 Posttranslational Modification of Proteins | 4238 | ||
5.15.1 Introduction | 4238 | ||
5.15.2 Phosphorylation and Sulfation | 4241 | ||
5.15.3 Cysteine Disulfide Formation | 4248 | ||
5.15.4 Methylation | 4249 | ||
5.15.5 N-Acetylation | 4252 | ||
5.15.6 Hydroxylation | 4253 | ||
5.15.7 Glycosylation | 4254 | ||
5.15.8 ADP-Ribosylation | 4255 | ||
5.15.9 Prenylation | 4256 | ||
5.15.10 Biotin, Lipoate, and Phosphopantetheine Tethering | 4260 | ||
5.15.11 Conclusions | 4267 | ||
Acknowledgments | 4268 | ||
Abbreviations | 4268 | ||
References | 4270 | ||
5.16 Collagen Formation and Structure | 4274 | ||
5.16.1 Introduction | 4275 | ||
5.16.2 Molecular Structure and Biological Function of Collagen Types | 4275 | ||
5.16.3 Biosynthesis of Collagen Molecules | 4298 | ||
5.16.4 Collagen Peptides as a Model of the Triple Helix | 4307 | ||
5.16.5 Collagen Chain Selection, Trimerization, and Triple Helix Formation | 4311 | ||
5.16.6 Atomic Structures of the Collagen Triple Helix and Collagen Trimerization Domains | 4315 | ||
5.16.7 Other Collagens | 4323 | ||
References | 4323 | ||
5.17 Lipidation of Peptides and Proteins | 4336 | ||
5.17.1 Introduction | 4336 | ||
5.17.2 Synthesis of Lipidated Peptides | 4343 | ||
5.17.3 Synthesis of Lipidated Proteins | 4371 | ||
5.17.4 Conclusions | 4383 | ||
Acknowledgments | 4383 | ||
Abbreviations | 4383 | ||
References | 4385 | ||
5.18 Genetic Incorporation of Unnatural Amino Acids into Proteins | 4392 | ||
5.18.1 Introduction | 4392 | ||
5.18.2 Methodology | 4393 | ||
5.18.3 Applications | 4406 | ||
5.18.4 Future Developments | 4418 | ||
Glossary | 4419 | ||
References | 4420 | ||
5.19 Nonribosomal Peptide Synthetases | 4424 | ||
5.19.1 Introduction: Peptide-Based Natural Products | 4425 | ||
5.19.2 Nonribosomal Peptide Natural Products | 4426 | ||
5.19.3 The Canonical Enzymology of NRPS Modules | 4426 | ||
5.19.4 Classes of Nonribosomal Peptide Synthetases | 4428 | ||
5.19.5 Noncanonical Features of NRPSs | 4437 | ||
5.19.6 Additional Enzyme Domains that Function in the NRPS Assembly Line | 4440 | ||
5.19.7 Structure and Chemistry of NRPS Domains | 4443 | ||
5.19.8 Pathways to Nonproteinogenic Amino Acids Incorporated into NRP Natural Products | 4449 | ||
5.19.9 Chemical Approaches Toward Mechanistic Probes and Inhibitors of NRPS Enzymes | 4453 | ||
5.19.10 Conclusions | 4455 | ||
References | 4456 | ||
5.20 The Properties, Formation, and Biological Activity of 2,5-Diketopiperazines | 4462 | ||
5.20.1 Introduction | 4463 | ||
5.20.2 What Are Cyclic Dipeptides? | 4464 | ||
5.20.3 Historical Aspects and Naturally Occurring Diketopiperazines | 4465 | ||
5.20.4 Structural Types and Classes of Cyclic Dipeptides | 4465 | ||
5.20.5 Properties of Diketopiperazines | 4466 | ||
5.20.6 Structural Relevance | 4470 | ||
5.20.7 Relevance of Amino Acids | 4475 | ||
5.20.8 Formation of 2,5-Diketopiperazines | 4480 | ||
5.20.9 Biological Relevance | 4486 | ||
Glossary | 4494 | ||
Abbreviations | 4495 | ||
Nomenclature | 4496 | ||
References | 4497 | ||
5.21 Ubiquitin-Dependent Protein Degradation | 4504 | ||
5.21.1 Discovery of the Ubiquitin–Proteasome Pathway | 4505 | ||
5.21.2 The Ubiquitin–Proteasome Pathway | 4506 | ||
5.21.3 Ubiquitin-Conjugating Enzymes: E1, E2, and E3 | 4507 | ||
5.21.4 Regulation of the Ubiquitin–Proteasome Pathway | 4511 | ||
5.21.5 Combinatorial Coding of Specificity in Ubiquitin Conjugation | 4514 | ||
5.21.6 The Proteasome | 4515 | ||
5.21.7 Regulation of the Proteasome | 4517 | ||
5.21.8 COP9 Signalosome | 4519 | ||
5.21.9 Deubiquitinating Enzymes | 4520 | ||
5.21.10 Ubiquitination and Endocytosis | 4524 | ||
5.21.11 The Ubiquitin–Proteasome Pathway and Endoplasmic Reticulum-Associated Degradation | 4528 | ||
5.21.12 The Ubiquitin–Proteasome Pathway and Transcription | 4528 | ||
5.21.13 Ubiquitin-Like Proteins | 4535 | ||
5.21.14 Unusual Linkages of Ubiquitin | 4538 | ||
5.21.15 Ubiquitin and Signaling | 4539 | ||
5.21.16 Physiological Functions of the Ubiquitin–Proteasome Pathway | 4539 | ||
5.21.17 Diseases Associated with the Ubiquitin–Proteasome Pathway | 4542 | ||
5.21.18 Future Perspectives | 4547 | ||
Abbreviations | 4547 | ||
References | 4548 | ||
e9780080453811v6 | 4558 | ||
Cover | 4558 | ||
Title page | 4561 | ||
Copyright page | 4562 | ||
Contents | 4563 | ||
Contributors | 4565 | ||
Preface | 4569 | ||
Introduction | 4571 | ||
Editors-In-Chief | 4575 | ||
Volume Editors | 4577 | ||
6.01 Overview and Introduction | 4583 | ||
6.01.1 Introduction | 4583 | ||
6.01.2 Overview | 4583 | ||
6.02 Enzymatic Synthesis of Complex Carbohydrates | 4587 | ||
6.02.1 Introduction | 4587 | ||
6.02.2 Glycosidases | 4590 | ||
6.02.3 Glycosynthases | 4597 | ||
6.02.4 Glycosyltransferases | 4605 | ||
6.02.5 Outlook | 4629 | ||
Abbreviations | 4630 | ||
Nomenclature | 4631 | ||
6.03 New Strategies for Glycopeptide, Neoglycopeptide, and Glycoprotein Synthesis | 4637 | ||
6.03.1 Introduction | 4637 | ||
6.03.2 Synthesis of Glycopeptides | 4640 | ||
6.03.3 Synthesis of Neoglycopeptide | 4657 | ||
6.03.4 Glycoprotein Synthesis | 4661 | ||
6.03.5 Conclusions | 4666 | ||
Abbreviations | 4666 | ||
6.04 Carbohydrate Vaccines | 4673 | ||
6.04.1 Introduction | 4673 | ||
6.04.2 Tumor-Associated Carbohydrate Antigens | 4674 | ||
6.04.3 TACA-Based Cancer Vaccine Development | 4676 | ||
6.04.4 Conclusion | 4697 | ||
Acknowledgment | 4698 | ||
6.05 MS-Based Glycoanalysis | 4705 | ||
6.05.1 Introduction | 4706 | ||
6.05.2 Diversity in Eukaryotic Protein Glycosylation | 4707 | ||
6.05.3 Workflows in MS-Based Protein Glycosylation Analysis | 4710 | ||
6.05.4 MS/MS Glycan Sequencing | 4721 | ||
6.05.5 Targeted Glycomics, Glycoproteomics, and the Way Forward | 4731 | ||
Abbreviations | 4734 | ||
6.06 Glycoanalysis of Bacterial Glycome | 4739 | ||
6.06.1 Introduction | 4739 | ||
6.06.2 Protein Glycosylation | 4740 | ||
6.06.3 Lipopolysaccharide | 4741 | ||
6.06.4 Capsular Polysaccharides | 4750 | ||
6.06.5 Conclusions | 4751 | ||
Acknowledgments | 4751 | ||
Abbreviations | 4751 | ||
Nomenclature | 4752 | ||
6.07 Chemical Glycobiology | 4757 | ||
6.07.1 Introduction | 4757 | ||
6.07.2 Synthetic Glycans with Biological Activity | 4758 | ||
6.07.3 Chemoenzymatic Synthesis to Study Glycan Structure and Function | 4769 | ||
6.07.4 Applications of Metabolic Oligosaccharide Engineering | 4779 | ||
6.07.5 Covalently Trapping Glycan Interactions with Photocross-linkers | 4786 | ||
Abbreviations | 4799 | ||
6.08 Alkaloid Glycosidase Inhibitors | 4807 | ||
6.08.1 Introduction | 4807 | ||
6.08.2 Chemistry of Alkaloid Glycosidase Inhibitors | 4808 | ||
6.08.3 Glycosidase Inhibition | 4819 | ||
6.08.4 Biological Activity of Glycosidase Inhibitors | 4821 | ||
6.08.5 Structure and Biosynthesis of N-Linked Glycoproteins | 4822 | ||
6.08.6 Structure and Synthesis of Glycosphingolipids | 4828 | ||
6.08.7 Therapeutic Activities of Glycosidase Inhibitors | 4833 | ||
Abbreviations | 4836 | ||
6.09 Molecular Probes for Protein Glycosylation | 4843 | ||
6.09.1 Introduction | 4843 | ||
6.09.2 Protein Glycosylation in Eukaryotes | 4845 | ||
6.09.3 Protein Glycosylation in Prokaryotes | 4850 | ||
6.09.4 Chemical Approaches toward Understanding Protein Glycosylation | 4850 | ||
6.09.5 Production of Homogeneous Glycoproteins | 4851 | ||
6.09.6 Chemical Probes for Perturbing Protein Glycosylation | 4859 | ||
6.09.7 Global Analysis of Protein Glycosylation | 4864 | ||
6.09.8 Microarray Platforms for Glycomics | 4872 | ||
6.09.9 Conclusions and Future Perspectives | 4873 | ||
Acknowledgments | 4873 | ||
Nomenclature | 4873 | ||
6.10 O Antigen Biosynthesis | 4879 | ||
6.10.1 Introduction | 4879 | ||
6.10.2 Biogenesis of O Antigen | 4880 | ||
6.10.3 Future Prospects | 4892 | ||
Acknowledgments | 4892 | ||
6.11 Biosynthesis of Complex Mucin-Type O-Glycans | 4897 | ||
6.11.1 Introduction | 4897 | ||
6.11.2 Mucins | 4898 | ||
6.11.3 Mucin-Type O-Glycans | 4900 | ||
6.11.4 Functions of O-Glycans and Changes of O-Glycan Structures in Disease | 4902 | ||
6.11.5 Biosynthesis of O-Glycans | 4904 | ||
6.11.6 Structures and Mechanisms of Glycosyltransferases | 4905 | ||
6.11.7 Initiation of O-Glycosylation | 4906 | ||
6.11.8 Synthesis of Core 1 | 4908 | ||
6.11.9 Synthesis of Core 2 | 4909 | ||
6.11.10 Synthesis of Core 3 | 4913 | ||
6.11.11 Synthesis of Core 4 | 4914 | ||
6.11.12 Synthesis of Minor Core Structures | 4915 | ||
6.11.13 Extension and Branching Reactions | 4915 | ||
6.11.14 The \x023- and \x024-Gal-Transferase Families | 4917 | ||
6.11.15 Sialyltransferases | 4918 | ||
6.11.16 Fucosyltransferases | 4921 | ||
6.11.17 Blood Group Transferases | 4923 | ||
6.11.18 Sulfotransferases | 4924 | ||
6.11.19 Future Needs and Directions | 4925 | ||
Acknowledgments | 4926 | ||
Abbreviations | 4926 | ||
6.12 Bacterial Protein Glycosylation | 4933 | ||
6.12.1 Introduction | 4933 | ||
6.12.2 Protein N-Glycosylation and O-Glycosylation at a Glance | 4934 | ||
6.12.3 General Protein N-Glycosylation System in Campylobacter jejuni | 4935 | ||
6.12.4 Protein O-Glycosylation in Gram-Negative Bacteria | 4937 | ||
6.12.5 Protein O-Glycosylation in Gram-Positive Bacteria | 4949 | ||
6.12.6 Protein O-Mannosylation in Mycobacteria | 4950 | ||
6.12.7 Challenges in the Study of Bacterial Protein Glycosylation | 4951 | ||
6.12.8 Glycoengineering in Bacteria | 4951 | ||
6.12.9 Concluding Remarks | 4956 | ||
Abbreviations | 4957 | ||
6.13 Structure and Biosynthesis of the Mycobacterial Cell Wall | 4963 | ||
6.13.1 Introduction | 4963 | ||
6.13.2 Peptidoglycan | 4964 | ||
6.13.3 Arabinogalactan | 4964 | ||
6.13.4 Phosphatidylinositol Mannoside, Lipomannan, Lipoarabinomannan, and Arabinomannan Structure | 4965 | ||
6.13.5 Peptidoglycan Synthesis | 4967 | ||
6.13.6 Biosynthesis of Arabinogalactan | 4970 | ||
6.13.7 Biosynthesis of the Phosphatidylinositol Containing Phosphatidylinositol Mannosides, Lipomannans, and Lipoarabinomannans | 4977 | ||
6.13.8 Mycobacterial Cell Envelope Ultrastructure | 4979 | ||
Acknowledgment | 4983 | ||
6.14 Structure, Biosynthesis, and Function\rof Glycosaminoglycans | 4989 | ||
6.14.1 Introduction | 4989 | ||
6.14.2 Heparan Sulfate and Heparin | 4989 | ||
6.14.3 Chondroitin Sulfate and Dermatan Sulfate | 5001 | ||
6.14.4 Other Glycosaminoglycans | 5003 | ||
Acknowledgments | 5004 | ||
Abbreviations | 5004 | ||
6.15 Biochemistry and Molecular Biology of Glycogen Synthesis in Bacteria and Mammals and Starch Synthesis in Plants | 5011 | ||
6.15.1 Introduction | 5012 | ||
6.15.2 The Role of Glycogen and Starch | 5013 | ||
6.15.3 Synthesis of Bacterial Glycogen and Plant Starch | 5014 | ||
6.15.4 Properties of the Bacterial and Plant Enzymes Involved in the Synthesis of Glycogen and Starch | 5016 | ||
6.15.5 Regulation of the Synthesis of Bacterial Glycogen and Starch | 5018 | ||
6.15.6 Subcellular Localization of ADP-Glc PPase in Plants | 5033 | ||
6.15.7 Crystal Structure of Potato Tuber ADP-Glc PPase | 5033 | ||
6.15.8 Bacterial Glycogen Synthase | 5034 | ||
6.15.9 Starch Synthases | 5037 | ||
6.15.10 Branching Enzyme | 5046 | ||
6.15.11 Other Enzymes Involved in Starch Synthesis | 5051 | ||
6.15.12 Genetic Regulation of Bacterial Glycogen Synthesis | 5052 | ||
6.15.13 Properties of the Glycogen Biosynthetic Enzymes of Mammals | 5054 | ||
6.15.14 Regulation of Mammalian Glycogen Synthesis | 5058 | ||
6.16 Celluloses | 5075 | ||
6.16.1 Introduction | 5075 | ||
6.16.2 Structures and States of Aggregation | 5076 | ||
6.16.3 Structural Studies | 5079 | ||
6.16.4 New Spectroscopic Methods | 5080 | ||
6.16.5 The Need for a New Paradigm | 5086 | ||
6.16.6 Further Studies of Structures in Cellulose | 5091 | ||
6.16.7 Computational Modeling | 5096 | ||
6.16.8 Polymorphy in Cellulose | 5098 | ||
6.16.9 Chemical Implications of Structure | 5099 | ||
6.16.10 Cellulose Structures in Summary | 5102 | ||
6.16.11 Cellulose Chemistry | 5103 | ||
Glossary | 5117 | ||
Abbreviations | 5118 | ||
6.17 Vascular Plant Lignification: Biochemical/Structural Biology Considerations of Upstream Aromatic Amino Acid and Monolignol Pathways | 5123 | ||
6.17.1 Introduction | 5124 | ||
6.17.2 Biochemistry of Phenylalanine and Tyrosine Formation in Vascular Plants: The Entry Point to Phenylpropanoid Metabolism and to Lignification | 5125 | ||
6.17.3 Structural Biology Considerations for the Monolignol-F Biosynthetic Pathway Steps | 5139 | ||
6.17.4 Conclusions | 5177 | ||
Acknowledgments | 5177 | ||
6.18 Proanthocyanidins: Chemistry and Biology | 5187 | ||
6.18.1 Introduction | 5187 | ||
6.18.2 The Naming Convention | 5188 | ||
6.18.3 Flavans, Flavan-3-ols, Flavan-4-ols, and Flavan-3,4-diols as Building\rBlocks for Proanthocyanidins | 5190 | ||
6.18.4 Proanthocyanidins | 5204 | ||
6.18.5 Nonproanthocyanidins with Flavan or Flavan-3-ol Constituent Units | 5233 | ||
6.18.6 Conformation of Proanthocyanidins | 5233 | ||
6.18.7 HPLC–MS Analysis of Proanthocyanidins | 5235 | ||
6.18.8 Effects of Proanthocyanidins on Human Health and Nutrition | 5235 | ||
6.19 Nucleoside Analogues | 5245 | ||
6.19.1 Introduction | 5245 | ||
6.19.2 Stereoelectronic Factors that Affect Nucleic Acid Stability | 5247 | ||
6.19.3 2-O-Methyl and 29-Fluoro Modification | 5248 | ||
6.19.4 Pseudouridine | 5250 | ||
6.19.5 Base-Modified Nucleosides in tRNA | 5254 | ||
6.19.6 Summary and Future Prospects | 5260 | ||
6.20 RNA Modifying Enzymes | 5265 | ||
6.20.1 Introduction | 5265 | ||
6.20.2 Methylation | 5266 | ||
6.20.3 Thiolation and Selenation | 5278 | ||
6.20.4 Deamination | 5282 | ||
6.20.5 Alkylation | 5287 | ||
6.20.6 Reduction/Oxidation | 5291 | ||
6.20.7 Transglycosylation | 5294 | ||
6.20.8 Complex Modifications | 5305 | ||
6.20.9 Conclusions and Perspectives | 5313 | ||
Abbreviations | 5315 | ||
6.21 Riboswitches | 5325 | ||
6.21.1 Introduction | 5325 | ||
6.21.2 Mechanisms of Gene Regulation | 5326 | ||
6.21.3 Regulatory Signals | 5328 | ||
6.21.4 Structure of Riboswitch RNAs | 5335 | ||
6.21.5 Riboswitches and Gene Identification | 5336 | ||
6.21.6 Using Riboswitches to Control Gene Expression | 5337 | ||
6.21.7 Perspectives and Future Directions | 5338 | ||
Glossary | 5339 | ||
e9780080453811v7 | 5343 | ||
Cover | 5343 | ||
Title Page | 5346 | ||
Copyright Page | 5347 | ||
Contents | 5348 | ||
Contributors | 5350 | ||
Preface | 5354 | ||
Introduction | 5356 | ||
Editors in Chief | 5360 | ||
Volume Editors | 5362 | ||
7.01 Overview and Introduction | 5368 | ||
7.02 Riboflavin Biosynthesis | 5370 | ||
7.02.1 Introduction | 5370 | ||
7.02.2 GTP Cyclohydrolase II | 5371 | ||
7.02.3 Deaminase/Reductase | 5375 | ||
7.02.4 3,4-Dihydroxy-2-Butanone 4-Phosphate Synthase | 5378 | ||
7.02.5 Lumazine Synthase | 5379 | ||
7.02.6 Riboflavin Synthase | 5382 | ||
7.02.7 Pentameric Riboflavin Synthases of Archaea | 5389 | ||
7.02.8 Lumazine Protein | 5390 | ||
7.02.9 Regulation of Riboflavin Biosynthesis | 5390 | ||
7.02.10 Biotechnology | 5395 | ||
7.02.11 Riboflavin Biosynthesis Genes as Potential Drug Targets | 5395 | ||
7.02.12 Riboflavin Kinase and FAD Synthetase | 5396 | ||
7.02.13 Biosynthesis of Deazaflavin Cofactors | 5396 | ||
7.02.14 Riboflavin as Substrate for Other Biosynthetic Pathways | 5396 | ||
References | 5399 | ||
7.03 Flavin-Dependent Enzymes | 5404 | ||
7.03.1 Introduction | 5405 | ||
7.03.2 Oxidation of Carbon–Heteroatom Bonds | 5409 | ||
7.03.3 Oxidation and Reduction of Carbon–Carbon Bonds | 5423 | ||
7.03.4 Thiol/Disulfide Chemistry | 5432 | ||
7.03.5 Electron Transfer Reactions | 5439 | ||
7.03.6 Oxygen Reactions | 5443 | ||
7.03.7 Nonredox Reactions | 5454 | ||
7.03.8 Complex Flavoenzymes | 5463 | ||
7.03.9 Summary | 5468 | ||
Abbreviations | 5468 | ||
References | 5470 | ||
7.04 Biotechnology of Riboflavin Production | 5482 | ||
7.04.1 Scope | 5482 | ||
7.04.2 Introduction | 5483 | ||
7.04.3 Industrial Production | 5484 | ||
7.04.4 Riboflavin Biosynthesis | 5487 | ||
7.04.5 Construction of Riboflavin Production Strains | 5490 | ||
7.04.6 Process Development | 5499 | ||
7.04.7 Conclusions | 5502 | ||
References | 5503 | ||
7.05 The Use of Subsystems to Encode Biosynthesis of Vitamins and Cofactors | 5508 | ||
7.05.1 The Goal | 5508 | ||
7.05.2 More Precisely, What Is a Subsystem? | 5510 | ||
7.05.3 How Are Subsystems Built? | 5517 | ||
7.05.4 What Is Revealed by the Construction of Subsystems? | 5521 | ||
7.05.5 The Project to Annotate 1000 Genomes | 5522 | ||
7.05.6 Summary | 5522 | ||
Acknowledgments | 5523 | ||
Abbreviations | 5523 | ||
References | 5523 | ||
7.06 Biosynthesis of Biotin | 5528 | ||
7.06.1 Introduction | 5528 | ||
7.06.2 The Biosynthetic Pathway | 5528 | ||
References | 5545 | ||
7.07 Lipoic Acid Biosynthesis and Enzymology | 5548 | ||
7.07.1 Introduction | 5548 | ||
7.07.2 The Biological Functions of Lipoamide | 5550 | ||
7.07.3 Pathways for Construction of the Lipoyl Cofactor | 5557 | ||
7.07.4 Characterization of Enzymes Involved in Lipoic Acid Biosynthesis and Metabolism | 5560 | ||
Acknowledgment | 5573 | ||
Glossary | 5573 | ||
References | 5575 | ||
7.08 Genomics and Enzymology of NAD Biosynthesis | 5580 | ||
7.08.1 Introduction | 5580 | ||
7.08.2 Biochemical Transformations and Enzymes | 5581 | ||
7.08.3 Genomic Reconstruction of NAD Biosynthetic Pathways | 5608 | ||
Acknowledgments | 5617 | ||
Abbreviations | 5617 | ||
References | 5618 | ||
7.09 Pyridoxal Phosphate Biosynthesis | 5626 | ||
7.09.1 Introduction | 5626 | ||
7.09.2 Enzymology of PLP Biosynthesis via the DXP-Dependent Route | 5627 | ||
7.09.3 Enzymology of PLP Biosynthesis via the R5P-Dependent Route | 5632 | ||
7.09.4 Transport, Salvage, and Interconversion of Various Forms of Vitamin B6 | 5634 | ||
7.09.5 Conclusions | 5635 | ||
Glossary | 5635 | ||
Abbreviations | 5635 | ||
References | 5636 | ||
7.10 Pyridoxal 5Prime-Phosphate-Dependent Enzymes: Catalysis, Conformation, and Genomics | 5640 | ||
7.10.1 Introduction | 5641 | ||
7.10.2 Reactivity of Amino Acids at Alpha-Position | 5647 | ||
7.10.3 Reactivity of Amino Acids at Beta-Position | 5662 | ||
7.10.4 Reactivity of Amino Acids at Gamma-Position | 5673 | ||
7.10.5 Radical Reactions in PLP-Enzymes | 5679 | ||
7.10.6 Reactivity with Inhibitors | 5682 | ||
7.10.7 Role of Conformational Changes in Substrate and Reaction Specificity and Allosteric Regulation | 5694 | ||
7.10.8 Genomics, Evolution, Structure, and Reactivity/Specificity | 5696 | ||
Acknowledgment | 5703 | ||
Glossary | 5703 | ||
Abbreviations | 5703 | ||
References | 5704 | ||
7.11 Coenzyme A Biosynthesis and Enzymology | 5718 | ||
7.11.1 Introduction | 5719 | ||
7.11.2 Coenzyme A and the Elucidation of Its Biosynthetic Pathway: A Historical Perspective | 5720 | ||
7.11.3 CoA Biosynthesis | 5722 | ||
7.11.4 CoA Utilization, Degradation, and Recycling | 5741 | ||
7.11.5 CoA-Dependent Enzymes | 5749 | ||
7.11.6 Chemical Biology Tools Based on CoA Enzymology | 5763 | ||
7.11.7 Drug Development Efforts Targeting CoA Enzymology | 5769 | ||
7.11.8 Conclusion | 5770 | ||
References | 5770 | ||
7.12 Menaquinone/Ubiquinone Biosynthesis and Enzymology | 5778 | ||
7.12.1 Introduction | 5778 | ||
7.12.2 Menaquinone Biosynthesis | 5781 | ||
7.12.3 Phylloquinone Biosynthesis | 5792 | ||
7.12.4 Ubiquinone Biosynthesis | 5793 | ||
7.12.5 Organization of Q Biosynthetic Enzymes into a Complex | 5803 | ||
7.12.6 Comparison of Q Biosynthesis in Yeast and Escherichia coli | 5803 | ||
7.12.7 Biosynthesis of Isoprenoid Side Chain of MK and Q | 5806 | ||
Acknowledgments | 5806 | ||
Abbreviations | 5806 | ||
References | 5807 | ||
7.13 Biosynthesis of Heme and Vitamin B12 | 5812 | ||
7.13.1 Tetrapyrroles – The Pigments of Life | 5813 | ||
7.13.2 Tetrapyrrole Biosynthetic Pathways | 5813 | ||
7.13.3 Formation of 5-Aminolevulinic Acid | 5815 | ||
7.13.4 Conversion of 5-Aminolevulinic Acid into Uroporphyrinogen III | 5820 | ||
7.13.5 Tetrapyrrole Biosynthesis Branch Point – Uroporphyrinogen III | 5826 | ||
7.13.6 Conversion of Uroporphyrinogen III into Protoheme | 5826 | ||
7.13.7 The Biosynthesis of Adenosylcobalamin (Vitamin B12) | 5832 | ||
7.13.8 A Note on Nomenclature | 5832 | ||
7.13.9 Overview of Cobalamin Biosynthesis | 5836 | ||
7.13.10 Uroporphyrinogen III to Precorrin-2 | 5836 | ||
7.13.11 The Aerobic Pathway | 5841 | ||
7.13.12 The Anaerobic Pathway – From Precorrin-2 to Adenosylcobyric Acid | 5848 | ||
7.13.13 Biosynthesis of Cobinamide (Phosphate) | 5853 | ||
7.13.14 Nucleotide Loop Assembly | 5856 | ||
References | 5860 | ||
7.14 Cobalamin Coenzymes in Enzymology | 5868 | ||
7.14.1 Introduction | 5869 | ||
7.14.2 Early Theories of B12 Function | 5870 | ||
7.14.3 Cobalamin Chemistry | 5873 | ||
7.14.4 Adenosylcobalamin in Enzymatic Catalysis | 5876 | ||
7.14.5 Methylcobalamin in Enzymatic Catalysis | 5905 | ||
7.14.6 Conclusion | 5907 | ||
Acknowledgment | 5908 | ||
Abbreviations | 5908 | ||
Nomenclature | 5909 | ||
References | 5909 | ||
7.15 Thiamin Biosynthesis | 5914 | ||
7.15.1 Introduction | 5914 | ||
7.15.2 Thiamin Biosynthesis in Bacillus subtilis | 5914 | ||
7.15.3 Thiamin Phosphate Synthase | 5915 | ||
7.15.4 Biosynthesis of the Thiazole Moiety of Thiamin in Bacteria | 5916 | ||
7.15.5 Protein Thiocarboxylates as Sulfide Carriers in Thiamin Biosynthesis | 5917 | ||
7.15.6 Formation of the Glycine Imine | 5918 | ||
7.15.7 Formation of the Pyrimidine Moiety of Thiamin | 5918 | ||
7.15.8 Kinases Involved in Thiamin Biosynthesis | 5920 | ||
7.15.9 Thiamin Salvage | 5920 | ||
7.15.10 Chemoenzymatic Synthesis of Thiamin Pyrophosphate | 5921 | ||
7.15.11 Thiamin Biosynthesis in Saccharomyces cerevisiae | 5922 | ||
7.15.12 Formation of the Thiamin Thiazole in Yeast | 5922 | ||
7.15.13 Formation of the Thiamin Pyrimidine in Yeast | 5923 | ||
7.15.14 Conclusions | 5923 | ||
References | 5924 | ||
7.16 Thiamin Enzymology | 5928 | ||
7.16.1 Introduction | 5929 | ||
7.16.2 Detection of Thiamin Diphosphate-Related Intermediates and Their Kinetic Fates, and the Information Gained from Such Data | 5929 | ||
7.16.3 Determination of Rate-Limiting Steps and Microscopic Rate Constants on ThDP Enzymes | 5946 | ||
7.16.4 Function and Dynamics of Mobile Loops on YPDC and E1ec | 5947 | ||
7.16.5 Structure–Function Studies in ThDP-Initiated Multienzyme Complex Reactions at the E1 (ThDP-Dependent) Component | 5954 | ||
7.16.6 Probing ThDP Enzyme Mechanisms with Coenzyme Analogs | 5957 | ||
7.16.7 Active Center Communication in ThDP Enzymes | 5957 | ||
7.16.8 Continuing Fascination with Thiamin Enzymes as Paradigm for Enzymatic Solvent Effects | 5960 | ||
7.16.9 Perspective for Future Studies | 5961 | ||
Acknowledgments | 5962 | ||
Abbreviations | 5962 | ||
References | 5962 | ||
7.17 The Biosynthesis of Folate and Pterins and Their Enzymology | 5966 | ||
7.17.1 Introduction | 5967 | ||
7.17.2 The Biosynthesis of Folate | 5969 | ||
7.17.3 Tetrahydrobiopterin Metabolism and Function | 5983 | ||
7.17.4 Molybdopterin and Molybdenum Cofactor Biosynthesis | 5995 | ||
Acknowledgments | 6006 | ||
Abbreviations | 6006 | ||
References | 6008 | ||
7.18 Cofactor Catabolism | 6016 | ||
7.18.1 Introduction | 6016 | ||
7.18.2 Vitamin B6 Catabolism | 6016 | ||
7.18.3 Heme Catabolism | 6019 | ||
7.18.4 Vitamin B3 Catabolism | 6024 | ||
7.18.5 Vitamin B2 Catabolism | 6026 | ||
7.18.6 Vitamin B1 Catabolism | 6026 | ||
7.18.7 Vitamin B9, Folate Catabolism | 6026 | ||
7.18.8 Vitamin B7, Biotin Catabolism | 6029 | ||
7.18.9 Lipoate Catabolism | 6030 | ||
7.18.10 Other Cofactors | 6030 | ||
7.18.11 Conclusion | 6030 | ||
Acknowledgment | 6032 | ||
Glossary | 6036 | ||
Abbreviations | 6036 | ||
References | 6037 | ||
7.19 Protein-Derived Cofactors | 6042 | ||
7.19.1 Introduction | 6042 | ||
7.19.2 Pyruvoyl Cofactor – A Product of Peptide Cleavage | 6044 | ||
7.19.3 4-Methylideneimidazole-5-One – A Product of Peptide Cyclization and Dehydration | 6047 | ||
7.19.4 Protein-Derived Quinone Cofactors | 6049 | ||
7.19.5 Functional Covalently Cross-Linked Amino Acid Residues in Metalloproteins | 6062 | ||
7.19.6 Green Fluorescent Protein and Protein-Derived Fluorophores | 6068 | ||
7.19.7 Pyrroloquinoline Quinone, a Protein-Derived Exogenous Cofactor | 6070 | ||
7.19.8 Lantibiotics, Protein-Derived Antibiotic Peptides | 6073 | ||
7.19.9 Conclusions and Perspectives | 6074 | ||
Abbreviations | 6074 | ||
References | 6075 | ||
7.20 Biosynthesis of the Methanogenic Coenzymes | 6078 | ||
7.20.1 Introduction | 6078 | ||
7.20.2 Biosynthesis of Methanofuran | 6079 | ||
7.20.3 Biosynthesis of Methanopterin | 6083 | ||
7.20.4 Biosynthesis of Coenzyme F420 and Riboflavin Precursors | 6091 | ||
7.20.5 Biosynthesis of Riboflavin, FMN, and FAD | 6097 | ||
7.20.6 Biosynthesis of Coenzyme M and Coenzyme B | 6102 | ||
7.20.7 Biosynthesis of Corrinoids and Coenzyme F430 | 6107 | ||
7.20.8 Concluding Remarks | 6112 | ||
References | 6112 | ||
e9780080453811v8 | 6116 | ||
Cover | 6116 | ||
Title Page | 6119 | ||
Copyright Page | 6120 | ||
Contents | 6121 | ||
Contributors | 6123 | ||
Preface | 6127 | ||
Introduction | 6129 | ||
Editors in Chief | 6133 | ||
Volume Editors | 6135 | ||
8.01 Overview and Introduction | 6141 | ||
8.01.1 Introduction | 6141 | ||
8.01.2 Chapter Summaries | 6142 | ||
References | 6147 | ||
8.02 Evolution and the Enzyme | 6149 | ||
8.02.1 Introduction | 6149 | ||
8.02.2 The Earliest Enzymes: Getting the Basic Chemistry in Place | 6150 | ||
8.02.3 Exploring Fold Space | 6155 | ||
8.02.4 Elaborating on the Basics | 6160 | ||
8.02.5 Enzyme Evolution in the Context of the Cell | 6175 | ||
8.02.6 Enzyme Evolution in the Modern Age | 6180 | ||
Abbreviations | 6183 | ||
References | 6184 | ||
8.03 Enzyme Promiscuity – Evolutionary and Mechanistic Aspects | 6187 | ||
8.03.1 Introduction | 6188 | ||
8.03.2 Promiscuity – The Rule or an Exception | 6188 | ||
8.03.3 The Definitions of Promiscuity | 6190 | ||
8.03.4 Quantifying the Degree and Magnitude of Promiscuity | 6192 | ||
8.03.5 Predicting Promiscuity | 6196 | ||
8.03.6 Mechanistic Aspects of Promiscuity | 6197 | ||
8.03.7 Promiscuity and the Divergence of Enzyme Superfamilies | 6202 | ||
8.03.8 Evolutionary Aspects of Promiscuity | 6206 | ||
Acknowledgments | 6223 | ||
Abbreviations | 6223 | ||
References | 6224 | ||
8.04 Mechanistic and Structural Studies of Microbial Dehalogenases: How Nature Cleaves a Carbon–Halogen Bond | 6229 | ||
8.04.1 Introduction | 6229 | ||
8.04.2 Dehalogenation Via Covalent Catalysis | 6230 | ||
8.04.3 Dehalogenation Via Noncovalent Catalysis | 6240 | ||
8.04.4 Structurally Undefined Dehalogenases | 6250 | ||
8.04.5 Conclusions | 6256 | ||
Acknowledgments | 6258 | ||
Abbreviations | 6258 | ||
Nomenclature | 6259 | ||
References | 6259 | ||
8.05 Guanidine-Modifying Enzymes in the Pentein Superfamily | 6265 | ||
8.05.1 Introduction to the Pentein Superfamily | 6266 | ||
8.05.2 Noncatalytic Proteins | 6267 | ||
8.05.3 Hydrolases | 6268 | ||
8.05.4 Dihydrolases | 6285 | ||
8.05.5 Amidinotransferases | 6288 | ||
8.05.6 Conclusion | 6294 | ||
Acknowledgments | 6295 | ||
References | 6295 | ||
8.06 Tunnels and Intermediates in the Glutamine-Dependent Amidotransferases | 6301 | ||
8.06.1 Introduction | 6302 | ||
8.06.2 Glutamine-Dependent Amidotransferases and Nitrogen Metabolism | 6303 | ||
8.06.3 Class I Amidotransferases | 6308 | ||
8.06.4 Class II Amidotransferases | 6335 | ||
8.06.5 Class III Amidotransferases | 6355 | ||
8.06.6 Other Aspects | 6359 | ||
8.06.7 Conclusion | 6361 | ||
Acknowledgment | 6361 | ||
References | 6361 | ||
8.07 Fatty Acid Biosynthesis and Oxidation | 6371 | ||
8.07.1 Introduction | 6371 | ||
8.07.2 Thiolase Enzyme Homologs | 6372 | ||
8.07.3 Oxidoreductases in Fatty Acid Biosynthesis and Breakdown | 6383 | ||
8.07.4 Hydratases and Dehydratases | 6398 | ||
8.07.5 Summary and Future Prospects | 6408 | ||
References | 6410 | ||
8.08 Diels-Alderases | 6417 | ||
8.08.1 Introduction | 6417 | ||
8.08.2 Enzymatic Formation of Diels–Alder Adducts | 6422 | ||
8.08.3 Diels–Alder Reaction Catalyzed by the Biological System | 6436 | ||
8.08.4 Enzyme-Catalyzed Diels–Alder Reactions | 6441 | ||
8.08.5 Natural Diels–Alder Adducts Whose Biosynthetic Gene Clusters Have Been Identified | 6447 | ||
8.08.6 Conclusions | 6450 | ||
References | 6451 | ||
8.09 Phosphoryl and Sulfuryl Transfer | 6455 | ||
8.09.1 Introduction | 6455 | ||
8.09.2 Uncatalyzed Reactions of Phosphate and Sulfate Monoesters | 6458 | ||
8.09.3 Key Features of Enzymatic Catalysis, and Structural Similarities between Sulfatases and Phosphatases | 6461 | ||
8.09.4 Enzymes that Catalyze the Hydrolysis of Phosphate Monoesters | 6462 | ||
8.09.5 Sulfatases | 6477 | ||
8.09.6 Conclusions | 6482 | ||
Abbreviation | 6482 | ||
References | 6483 | ||
8.10 Catalytic Mechanism of DNA Polymerases | 6489 | ||
8.10.1 Introduction | 6490 | ||
8.10.2 Polymerase Families | 6490 | ||
8.10.3 Structural Requirements for Polymerase Catalysis | 6492 | ||
8.10.4 General Mechanism of Nucleotide Incorporation Catalyzed by DNA Polymerases | 6495 | ||
8.10.5 Computational Studies | 6512 | ||
8.10.6 Final Thoughts | 6517 | ||
Abbreviations | 6518 | ||
Nomenclature | 6518 | ||
References | 6519 | ||
8.11 Mechanisms of Enzymatic Glycosyl Transfer | 6525 | ||
8.11.1 Introduction | 6525 | ||
8.11.2 Reaction Mechanisms of Glycoside Hydrolases | 6531 | ||
8.11.3 Examples of Mechanistic Studies of Some Representative Glycosidases | 6535 | ||
8.11.4 Glycosyltransferases | 6548 | ||
References | 6554 | ||
8.12 Synthesis of Alginate in Bacteria | 6563 | ||
8.12.1 Introduction | 6563 | ||
8.12.2 Alginate Structure | 6563 | ||
8.12.3 Overview of Alginate Biosynthesis | 6565 | ||
8.12.4 Phosphomannose Isomerase | 6566 | ||
8.12.5 Phosphomannomutase | 6567 | ||
8.12.6 Guanosine Diphosphate-Mannose Pyrophosphorylase | 6570 | ||
8.12.7 Guanosine Diphosphate-Mannose Dehydrogenase | 6570 | ||
8.12.8 Mannuronan Synthesis | 6572 | ||
8.12.9 C5-Mannuronan Epimerase | 6572 | ||
8.12.10 Alginate Acetylation | 6576 | ||
8.12.11 Alginate Lyase | 6577 | ||
8.12.12 Secretion of Alginate | 6578 | ||
8.12.13 Regulation of Alginate Synthesis | 6578 | ||
8.12.14 Future Directions | 6578 | ||
Abbreviations | 6579 | ||
References | 6579 | ||
8.13 Enzymology of Bacterial Resistance | 6583 | ||
8.13.1 Introduction | 6583 | ||
8.13.2 Enzymatic Basis for Beta-Lactam Resistance | 6584 | ||
8.13.3 Enzymatic Basis for Glycopeptide Resistance | 6595 | ||
8.13.4 Enzymatic Basis for Aminoglycoside Resistance | 6601 | ||
8.13.5 Enzymatic Basis for Macrolide and Ketolide Resistance | 6610 | ||
8.13.6 Enzymatic Basis for Resistance to the Quinolone Antibacterials | 6614 | ||
8.13.7 Conclusion | 6616 | ||
Abbreviations | 6616 | ||
References | 6616 | ||
8.14 Copper Metalloenzymes | 6629 | ||
8.14.1 Introduction | 6629 | ||
8.14.2 Copper Enzyme Catalysis | 6639 | ||
Acknowledgment | 6679 | ||
References | 6679 | ||
8.15 Mechanisms of Metal-Dependent Hydrolases in Metabolism | 6687 | ||
8.15.1 Introduction | 6687 | ||
8.15.2 Metal Ion Cofactors | 6688 | ||
8.15.3 Mononuclear Metallohydrolases | 6693 | ||
8.15.4 Binuclear Metallohydrolases | 6709 | ||
8.15.5 Conclusions | 6715 | ||
Abbreviations | 6716 | ||
References | 6717 | ||
8.16 Dioxygenase Enzymes and Oxidative Cleavage Pathways | 6723 | ||
8.16.1 Bacterial Aromatic Degradation Pathways | 6723 | ||
8.16.2 Mammalian Aromatic Amino Acid Degradation Pathways | 6743 | ||
8.16.3 Carotenoid Oxidative Cleavage Pathways | 6749 | ||
8.16.4 Other Dioxygenase Enzymes Involved in Catabolic and Biosynthetic Pathways | 6754 | ||
References | 6759 | ||
8.17 S-Adenosylmethionine and Iron–Sulfur Clusters in Biological Radical Reactions: The Radical SAM Superfamily | 6765 | ||
8.17.1 Introduction | 6766 | ||
8.17.2 Radical SAM Enzymes: A Common Mechanistic Start | 6770 | ||
8.17.3 Diverse Reactions Catalyzed by Radical SAM Enzymes | 6775 | ||
8.17.4 Insights from Structural Studies of Radical SAM Enzymes | 6790 | ||
8.17.5 Conclusions | 6797 | ||
Acknowledgements | 6797 | ||
Abbreviations | 6797 | ||
References | 6797 | ||
8.18 Detection of Novel Enzyme Intermediates | 6803 | ||
8.18.1 Introduction | 6803 | ||
8.18.2 Criteria for Establishing Enzyme Intermediates | 6804 | ||
8.18.3 Methodologies and Experimental Design for Optimal Intermediate Detection of Enzyme Intermediates | 6805 | ||
8.18.4 Selected Examples of Enzymological Studies Involving Detection and Characterization of Novel Enzyme Intermediates | 6811 | ||
8.18.5 Novel Approaches for Detecting and Characterizing Enzyme Intermediates | 6821 | ||
8.18.6 Conclusions | 6822 | ||
Acknowledgments | 6823 | ||
Abbreviations | 6824 | ||
References | 6824 | ||
8.19 Bisubstrate Analog Inhibitors | 6829 | ||
8.19.1 Introduction | 6829 | ||
8.19.2 Design and Analysis of Bisubstrate Analog Inhibitors | 6830 | ||
8.19.3 Gcn5-Related N-Acetyltransferases | 6831 | ||
8.19.4 Acetyl-CoA Carboxylase | 6837 | ||
8.19.5 Protein Kinases | 6838 | ||
8.19.6 Catechol-O-Methyltransferase | 6840 | ||
8.19.7 Farnesyltransferase | 6842 | ||
8.19.8 Current Bisubstrate Analogs as Therapeutics | 6844 | ||
8.19.9 Future Perspectives | 6853 | ||
Abbreviations | 6853 | ||
References | 6854 | ||
8.20 Quantum Chemical Modeling of Enzymatic Reactions – Applications to Epoxide-Transforming Enzymes | 6859 | ||
8.20.1 Introduction | 6859 | ||
8.20.2 Density Functional Theory | 6860 | ||
8.20.3 Modeling Enzyme Active Sites and Reactions | 6862 | ||
8.20.4 Applications to Epoxide-Transforming Enzymes | 6866 | ||
8.20.5 Conclusions and Outlook | 6884 | ||
Abbreviations | 6884 | ||
Nomenclature | 6885 | ||
References | 6885 | ||
e9780080453811v9 | 6889 | ||
Cover | 6889 | ||
Title Page | 6892 | ||
Copyright Page | 6893 | ||
Contents | 6894 | ||
Contributors | 6896 | ||
Preface | 6900 | ||
Introduction | 6902 | ||
Editors in Chief | 6906 | ||
Volume Editors | 6908 | ||
9.01 Overview and Introduction | 6914 | ||
9.02 High Performance Liquid Chromatographic Separation Methods | 6918 | ||
9.02.1 Introduction | 6918 | ||
9.02.2 Modes of Separation by HPLC in Natural Product Isolation | 6921 | ||
9.02.3 From Analytical to Preparative Scale Illustrated for HP-RPC | 6926 | ||
9.02.4 Multidimensional High-Performance Liquid Chromatography | 6933 | ||
9.02.5 HPLC Separation of Natural Products | 6939 | ||
9.02.6 Conclusions | 6954 | ||
Abbreviations | 6956 | ||
References | 6957 | ||
9.03 Introduction to Macromolecular X-Ray Crystallography | 6964 | ||
9.03.1 Introduction | 6964 | ||
9.03.2 Why Crystallography? | 6965 | ||
9.03.3 Protein Crystals | 6965 | ||
9.03.4 Obtaining Protein Crystals | 6967 | ||
9.03.5 Principles of Diffraction | 6970 | ||
9.03.6 Fourier Transforms | 6973 | ||
9.03.7 Diffraction as a Fourier Series | 6975 | ||
9.03.8 The Diffraction Experiment in Practice | 6976 | ||
9.03.9 Phasing Methods | 6980 | ||
9.03.10 The Electron Density Map | 6988 | ||
9.03.11 Model Building and Refinement | 6992 | ||
9.03.12 Model Validation | 6995 | ||
9.03.13 An Example of a Crystal Structure Determination | 6997 | ||
Acknowledgments | 7000 | ||
Nomenclature | 7000 | ||
References | 7000 | ||
9.04 Characterization by Circular Dichroism Spectroscopy | 7004 | ||
9.04.1 Introduction | 7005 | ||
9.04.2 OR of Chiral Compounds | 7005 | ||
9.04.3 Circular Dichroism Spectra | 7007 | ||
9.04.4 CD Exciton Chirality Method | 7013 | ||
9.04.5 Induced CD | 7029 | ||
9.04.6 Characterization of Natural Products by CD – Selected Examples | 7030 | ||
9.04.7 Concluding Remarks and Outlook | 7054 | ||
References | 7055 | ||
9.05 Determination of Structure including Absolute Configuration of Bioactive Natural Products | 7060 | ||
9.05.1 Introduction | 7060 | ||
9.05.2 Absolute Configuration and Sign of Optical Rotation | 7060 | ||
9.05.3 Elucidating the Structure of Pheromones of Stink Bugs | 7061 | ||
9.05.4 Absolute Configuration Involving Remote Stereocenters | 7062 | ||
9.05.5 Absolute Configuration Involving Stereocenters Separated by a Polymethylene Spacer | 7067 | ||
9.05.6 Origin of Biological Homochirality | 7071 | ||
9.05.7 Exceptions to Biological Homochirality | 7072 | ||
9.05.8 Mimics of Bioactive Natural Products and Bioisosterism | 7074 | ||
9.05.9 Inventions of Pesticides and Medicinals | 7076 | ||
9.05.10 Conclusion | 7077 | ||
Abbreviations | 7078 | ||
References | 7078 | ||
9.06 NMR – Small Molecules and Analysis of Complex Mixtures | 7082 | ||
9.06.1 Introduction | 7082 | ||
9.06.2 Routine NMR Spectroscopy for Natural Products Structure Elucidation | 7085 | ||
9.06.3 Complex Mixtures | 7092 | ||
9.06.4 Methods to Improve Sensitivity | 7100 | ||
9.06.5 Outlook | 7105 | ||
Abbreviations | 7105 | ||
References | 7106 | ||
9.07 Biomolecular Recognition by Oligosaccharides and Glycopeptides: The NMR Point of View | 7110 | ||
9.07.1 Scalar and Residual Dipolar Coupling Constants in the Structure Determination of Carbohydrates by NMR | 7111 | ||
9.07.2 Conformation of Oligosaccharides in the Free and Bound States | 7127 | ||
9.07.3 Bacterial Cell Wall Peptidoglycans and Fragments: Structural Studies and Functions | 7131 | ||
9.07.4 NMR of Glycopeptide (Vancomycin-Type) Antibiotics: Structure and Interaction with Cell Wall Analogue Peptides | 7140 | ||
Acknowledgments | 7147 | ||
Abbreviations | 7147 | ||
References | 7149 | ||
9.08 Determination of Three-Dimensional Structures of Nucleic Acids by NMR | 7160 | ||
9.08.1 Introduction | 7160 | ||
9.08.2 Sample Preparation | 7160 | ||
9.08.3 Resonance Assignments | 7166 | ||
9.08.4 Extracting Structural Information | 7171 | ||
9.08.5 Three-Dimensional Structure Refinement | 7181 | ||
Abbreviations | 7184 | ||
Nomenclature | 7185 | ||
References | 7185 | ||
9.09 Derivation of Peptide and Protein Structure using NMR Spectroscopy | 7192 | ||
9.09.1 Introduction | 7193 | ||
9.09.2 Sample Considerations and Solvent Suppression | 7194 | ||
9.09.3 Data Acquisition for Nonlabeled Peptides | 7201 | ||
9.09.4 Data Acquisition for Isotopically Labeled Proteins | 7210 | ||
9.09.5 Extraction of Structural Constraints | 7219 | ||
9.09.6 Calculation of Structures from NMR Data | 7226 | ||
9.09.7 Conclusions and Future Prospects | 7231 | ||
Acknowledgments | 7232 | ||
Abbreviations | 7232 | ||
Nomenclature | 7233 | ||
References | 7233 | ||
9.10 Mass Spectrometry: An Essential Tool for Trace Identification and Quantification | 7240 | ||
9.10.1 Introduction | 7241 | ||
9.10.2 Components of a Mass Spectrometer | 7242 | ||
9.10.3 Tandem Mass Spectrometry | 7262 | ||
9.10.4 Experimental Use of Mass Spectrometry | 7269 | ||
Acknowledgments | 7295 | ||
Abbreviations | 7295 | ||
Nomenclature | 7296 | ||
References | 7297 | ||
9.11 Applications of Modern Mass Spectrometry Techniques in Natural Products Chemistry | 7302 | ||
9.11.1 Introduction | 7303 | ||
9.11.2 Applications of Mass Spectrometry on NRPS Systems | 7320 | ||
9.11.3 Applications of Mass Spectrometry on PKS Systems | 7349 | ||
9.11.4 Prospective Applications of Current Natural Product MS Methods on NRPS and PKS Systems | 7359 | ||
9.11.5 Up-and-Coming Advances in Mass Spectrometry Tools for the Investigation of Natural Products and Their Biosynthetic Pathways | 7362 | ||
Acknowledgments | 7363 | ||
Abbreviations | 7363 | ||
Nomenclature | 7365 | ||
References | 7365 | ||
9.12 Mass Spectrometry: Structure Determination of Proteins and Peptides | 7370 | ||
9.12.1 Introduction | 7371 | ||
9.12.2 Proteomics: A Field of Protein Characterization | 7372 | ||
9.12.3 Mass Spectrometry Analysis of Proteomes | 7376 | ||
9.12.4 Protein Expression Profiling through Quantitative Proteomics | 7380 | ||
9.12.5 De Novo Sequencing of Peptides | 7383 | ||
9.12.6 Posttranslational Modifications in Proteins and Peptides | 7392 | ||
9.12.7 Higher-Order Structures of Proteins and Peptides | 7397 | ||
9.12.8 Monitoring Protein–Ligand Interactions | 7402 | ||
9.12.9 Conclusions | 7404 | ||
Abbreviations | 7405 | ||
References | 7406 | ||
9.13 Application of Mass Spectrometry to Rapid Analysis of Bacterial Polysaccharides | 7410 | ||
9.13.1 Introduction | 7410 | ||
9.13.2 In-Source Fragmentation and Analysis of Polysaccharides by Capillary Electrophoresis–Mass Spectrometry | 7411 | ||
9.13.3 Materials and Methods | 7419 | ||
9.13.4 Conclusions | 7421 | ||
Abbreviations | 7422 | ||
References | 7422 | ||
9.14 Modern Methods for the Isolation of Natural Product Receptors | 7426 | ||
9.14.1 Introduction | 7426 | ||
9.14.2 Traditional Approaches | 7429 | ||
9.14.3 Genome-Wide Approaches | 7431 | ||
9.14.4 Future Prospects | 7473 | ||
Glossary | 7473 | ||
References | 7474 | ||
9.15 Bioinformatics | 7482 | ||
9.15.1 Introduction | 7482 | ||
9.15.2 Measuring Biodiversity | 7484 | ||
9.15.3 Selected Data Mining Techniques for Gene Expression | 7486 | ||
9.15.4 Software in Bioinformatics | 7495 | ||
9.15.5 Structural Bioinformatics Approaches for Signaling Processes: A Case Study | 7498 | ||
9.15.6 Summary and Future Prospects | 7500 | ||
Abbreviations | 7501 | ||
References | 7502 | ||
9.16 Natural Products Research and Metabolomics | 7508 | ||
9.16.1 Introduction | 7508 | ||
9.16.2 Analytical Techniques | 7511 | ||
9.16.3 Modeling and Data Analysis | 7527 | ||
9.16.4 Sampling and Sample Preparation | 7530 | ||
9.16.5 Examples | 7530 | ||
9.16.6 Conclusion | 7537 | ||
Abbreviations | 7537 | ||
References | 7538 | ||
9.17 Small Molecules as Versatile Tools for Activity-Based Protein Profiling Experiments | 7542 | ||
9.17.1 Introduction | 7543 | ||
9.17.2 Principles of Activity-Based Protein Profiling | 7544 | ||
9.17.3 Chemical Probes for ABPP | 7552 | ||
9.17.4 Biological Applications | 7577 | ||
9.17.5 Conclusions and Outlook | 7581 | ||
References | 7583 | ||
9.18 Metabolic Studies Using the Retrobiosynthesis Concept – Theory, Technology, and Examples | 7588 | ||
9.18.1 Isotopes in Metabolic Sciences | 7588 | ||
9.18.2 Isotope Propagation in Metabolic Networks | 7589 | ||
9.18.3 A Quasi-Steady-State Concept of Isotope Distribution | 7590 | ||
9.18.4 A Rational Perturbation/Relaxation Strategy for Assessment of Metabolic Pathways | 7590 | ||
9.18.5 The Retrobiosynthesis Concept in Practical Terms | 7591 | ||
9.18.6 Isotopologue Space | 7592 | ||
9.18.7 Quantitative Assessment of Isotopologue Abundance | 7593 | ||
9.18.8 Application of the Retrobiosynthesis Concept to Studies in Biosynthesis | 7594 | ||
9.18.9 Conclusion and Outlook | 7605 | ||
Glossary | 7605 | ||
References | 7605 | ||
9.19 Bacterial Protein Overexpression Systems and Strategies | 7608 | ||
9.19.1 Introduction | 7609 | ||
9.19.2 Project Design | 7609 | ||
9.19.3 Escherichia Coli Expression | 7612 | ||
9.19.4 Cloning | 7615 | ||
9.19.5 Methods to Improve Expression and Solubility | 7618 | ||
9.19.6 Affinity Protein Purification | 7623 | ||
9.19.7 Conclusions | 7627 | ||
Abbreviations | 7627 | ||
References | 7628 | ||
9.20 Directed Evolution of Enzymes | 7636 | ||
9.20.1 Introduction | 7636 | ||
9.20.2 Library Construction Techniques and Consequences | 7642 | ||
9.20.3 Selection and Screening Techniques | 7648 | ||
9.20.4 Applications of Directed Molecular Evolution | 7650 | ||
9.20.5 Conclusions | 7658 | ||
Abbreviations | 7658 | ||
References | 7658 | ||
9.21 Single Molecule Fluorescence Methods in Enzymology | 7664 | ||
9.21.1 Introduction | 7664 | ||
9.21.2 Fluorescent Active Site | 7665 | ||
9.21.3 Fluorogenic Reaction | 7668 | ||
9.21.4 Fluorescent Substrate | 7671 | ||
9.21.5 Fluorescence Resonance Energy Transfer (FRET) | 7673 | ||
9.21.6 Fluorescence Quenching via Energy Transfer | 7675 | ||
9.21.7 Fluorescence Quenching via Electron Transfer | 7677 | ||
9.21.8 Summary | 7679 | ||
Acknowledgments | 7679 | ||
Abbreviations | 7679 | ||
References | 7679 | ||
e9780080453811v10 | 7684 | ||
Cover | 7684 | ||
Title Page | 7687 | ||
Copyright Page | 7688 | ||
Contents of all Volumes | 7689 | ||
Contributors to all Volumes | 7701 | ||
Preface | 7721 | ||
Introduction | 7723 | ||
Editors in Chief | 7727 | ||
Volume Editors | 7729 | ||
INDEX | 7735 |